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ABSTRACT 
 
As we migrate into an era of personalized medicine, understanding how 
bio-molecules interact with one another to form cellular systems is one of the key 
focus areas of systems biology. Several challenges such as the dynamic nature of 
cellular systems, uncertainty due to environmental influences, and the 
heterogeneity between individual patients render this a difficult task. In the last 
decade, several algorithms have been proposed to elucidate cellular systems from 
data, resulting in numerous data-driven hypotheses. However, due to the large 
number of variables involved in the process, many of which are unknown or not 
measurable, such computational approaches often lead to a high proportion of 
false positives. This renders interpretation of the data-driven hypotheses 
extremely difficult. Consequently, a dismal proportion of these hypotheses are 
subject to further experimental validation, eventually limiting their potential to 
augment existing biological knowledge. 
This dissertation develops a framework of computational methods for the 
analysis of such data-driven hypotheses leveraging existing biological knowledge. 
Specifically, I show how biological knowledge can be mapped onto these 
hypotheses and subsequently augmented through novel hypotheses. Biological 
hypotheses are learnt in three levels of abstraction -- individual interactions, 
functional modules and relationships between pathways, corresponding to three 
complementary aspects of biological systems. The computational methods 
developed in this dissertation are applied to high throughput cancer data, resulting 
in novel hypotheses with potentially significant biological impact. 
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Chapter 1
INTRODUCTION
Based on cancer incidence and mortality rates until 2007, the American Cancer
Society predicted that, in 2012, in the US alone [1], a total of 577,190 patients would
die due to cancer and 1,638,910 new occurrences of cancer would be diagnosed. This
indicates that although molecular biology has seen progress in the last decade, we are
still far from completely understanding the biological processes underlying disease.
The key causes for this, include, underestimating the complexity of biological
processes, heterogeneity among individual organisms, and the value of the genome
being limited by its annotation.
The complexity of biological processes arises from the coordinated activity of
biomolecules such as genes, proteins or complexes; heterogeneity, arises from
differences across individuals in the activity of these biomolecules; and limitations
of the genome arise from their functional diversity. Consequently, studying biological
processes, benefits from a systems approach. For example, the PI3K pathway [2], an
important pathway in cancer, regulates the signaling of multiple biological processes
including apoptosis, cell proliferation, and cell growth. Being up regulated in cancer,
this pathway is a promising target for therapy, as it is easier to inhibit activation
than suppress tumor function [2]. However, the pathway functions through the
interplay of biological interactions among several functionally diverse elements,
each of which is regulated differently in distinct individuals. Clearly, a traditional
reductionist approach which dissects this pathway into its constituent parts alone,
would have difficulty in elucidating how it is regulated [3]. Instead it is important to
adopt a systems approach to understand this pathway completely.
Systems biology views biological processes as an integrated network of genes,
1
proteins, and biomolecular interactions in continuous flux. Computational, statistical
and mathematical methods play an important role in this paradigm by facilitating
formal representations of complex biological systems. Additionally, they allow for
the automated inference of models from experimental data that is frequently too
large to manually analyze.
Recently, the popularity of high-throughput technology has led to not only a large
amount of experimental data but also the growth of biological knowledge reposito-
ries. Such knowledge repositories (for example, Gene Ontology [4, 5] or Pathway
Commons [6]) store facts about the functions of biomolecules and their interactions.
In most cases, the facts are manually curated and associated with literature citations.
This dissertation develops a framework of computational methods to aid in hy-
pothesis generation in systems biology using such available biological knowledge.
Specifically, it focuses on hypotheses generated about one of the core problems of
systems biology: how biomolecules interact in normal and diseased cellular systems.
The rest of this chapter is organized in a top-down manner. First, I place this
dissertation within the broad context of research in systems biology. Subsequently, I
provide an overview of the methods developed in this work. Finally, I outline the
rest of the document.
1.1 Knowledge Discovery in Systems Biology
Before describing the framework developed in this dissertation, I first discuss the
role of this dissertation in the workflows for scientific knowledge discovery. The
two modes of scientific knowledge discovery, hypothesis-driven research and data-
driven research, are illustrated in Figure 1.1. The structural components within
these workflows are data and knowledge, two distinct yet complementary sources
2
Figure 1.1: Knowledge discovery in systems biology.(a) Workflows for both
hypothesis-driven research (indicated by blue arrows) and data-driven research
(indicated by red arrows). (b) The role of knowledge integration (the focus of this
dissertation) in the workflow for data-driven research.
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of information. Data represents the collection of observations or the results of
experiments, usually influenced by environmental factors. Data is collected either
from focused individual experiments or from high-throughput experiments, shown
in Figure 1.1. Examples of biological data include, gene expression profiles, copy
number variations, and methylation data. Knowledge, on the other hand, represents
validated facts about biological systems. Knowledge is usually manually curated
with the help of several experts. Examples of biological knowledge bases include
pathway repositories and drug target databases.
Traditionally, biological hypotheses are validated by a hypothesis-driven approach,
through focused experiments, studying each hypothesis individually using experi-
mental wet-lab techniques. Such hypotheses, usually formulated by domain experts,
could take several forms, such as whether an interaction occurs between a pair of
biomolecules or the biological processes that characterize disease sub-types. Vali-
dation of the hypothesis involves focused experiments, gathering of biological data
and analysis of the data. Findings are usually disseminated through publications and,
later, curated into biological knowledge repositories.
In contrast, over the last decade, the widespread availability of large amounts of
high-throughput data has led to computational methods for inferring biological
hypotheses directly from the data, as shown in Figure 1.1, by the red arrows.
Such methods use an underlying mathematical framework, for example, a Bayesian
network framework, to learn hypotheses from various kinds of biological data. In
contrast to the hypotheses produced by domain experts, such hypotheses tend to
be of the order of a few hundred to a few thousand in number. Additionally, since
these hypotheses are derived by applying computational methods to high-throughput
data (which is often noise-ridden), not all hypotheses are necessarily biologically
plausible. Ideally, all data-driven hypotheses would be verified through further
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biological experimentation. However, wet-lab experiments are expensive and time-
consuming. Consequently, biologists need to manually sift through these hypotheses
to determine which ones are plausible for focused experimental validation. Such
manual analysis is a cumbersome process due to which only a handful of these
hypotheses are validated and the rest are discarded.
In this dissertation, I develop a systematic framework to automatically prioritize such
data-driven hypotheses using available biological knowledge. Biological knowledge
allows for better interpretation of the data-driven hypotheses by first mapping them
to what is currently known about biology and then augmenting what is known with
plausible novel hypotheses. I focus on three different levels of biological organization
– individual interactions, functional modules, and relationships between functional
modules.
1.2 Problem Definition
Now I turn to the computational framework developed in this work (shown in Figure
1.2). This dissertation develops methods for refining data-driven hypotheses using
existing biological knowledge at three layers of abstraction: individual interactions
(described in Chapter 3), functional modules (described in Chapter 4), and rela-
tionships between biological processes (described in Chapter 5). The input and
output of the framework are illustrated in Figure 1.2. Such hypotheses can then be
validated by a focused hypothesis-driven experiment. The three levels of abstraction
correspond to three complementary aspects of understanding biological systems,
which, when put together, provide a global understanding of a biological system.
In this dissertation, the three levels are treated as independent classes of problems.
While this work focuses primarily on hypotheses learned from high throughput data,
in theory, the hypotheses could be from any source.
5
Figure 1.2: Computational framework for knowledge integration (developed in this
dissertation).
Individual Interactions
I begin by focusing on hypotheses at the finest level of granularity - individual
interactions. Chapter 3 develops methods to score the constituent interactions
within a data-driven network to rank the most plausible interactions for further
biological validation. This chapter focuses on hypotheses that take the form of
data-driven interactions. Using literature-verified biological pathways and additional
functional knowledge, the interactions are scored for further validation. High-scoring
interactions can be immediately validated as they correspond directly to biological
interactions.
6
Functional Modules
At the second level of granularity, functional modules constitute a set of biomolecular
interactions that work towards a common biological purpose [7]. Such modules
constitute an important level of biological organization, often corresponding to
pathways. In Chapter 4, I focus on identifying functional modules within data-driven
networks, using existing biological knowledge. As in the previous chapter, the
input hypotheses take the form of data-driven networks of biomolecular interactions.
Using sets of genes with pre-defined biological roles, the data-driven networks
are partitioned into functional modules. Additionally, this chapter also overlays
drug information in the form of therapeutic targets. Functional modules identified
here can be used to understand the key biological processes that are active in
a given set of samples. Although these functional modules cannot be directly
experimentally validated, they provide a mechanism for biologists to focus on
a specific set of biological hypotheses, where each hypothesis corresponds to a
biomolecular interaction.
Relationships between Biological Processes
In contrast to the previous levels of granularity, at the third level of granularity, the
hypotheses take the form of biological processes or functions. In Chapter 5, I use
lists of co-regulated genes to identify the biological functions that are active within
the data and their relationships across sub-sets of the data. Additionally, knowledge
of existing relationships between the biological functions guides the process. While
this chapter also provides biologists with specific sets of biological hypotheses to
focus on, each hypothesis corresponds to a biological process that is active within
the data. Hence, this chapter allows for identifying novel co-occurrence relationships
7
between biological processes.
Figure 1.3: Overall inputs and outputs for the knowledge integration framework.
1.3 Dissertation Overview
The rest of this document provide the details of the methods for knowledge integra-
tion in the analysis of data-driven networks. Chapter 2 describes related research in
this field. Chapter 3 describes methods for scoring individual interactions against
a literature-verified database. Chapter 4 describes the methods proposed for the
identification of functional modules from data-driven networks using biological gene
sets. Chapter 5 focuses upon methods for learning relationships between biological
processes active in the high-throughput data. Chapter 6 describes an example focused
hypothesis-driven experiment, illustrating how the output of Chapters 3 - 5 could be
validated. Finally, Chapter 7 concludes with a summary of the main contributions of
the dissertation and directions for future research.
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Chapter 2
RELATED RESEARCH
Cellular systems are complex biological processes and identifying the constituent
interactions of such systems is one of the core problems of systems biology. As
described in Chapter 1, solving this problem could use either a hypothesis-driven or
a data-driven approach. However, both approaches rely on the experimental observa-
tion of biological processes for either formulation or validation of the hypotheses (in
this case, the existence of specific interactions). Technological advances in the last
decade allow for diverse experiments which shed light on the different aspects of
biological processes. In this chapter, I describe the different kinds of biological data
that are currently available. Following this, I outline existing research in methods for
generating hypotheses from the data - specifically the inference of gene regulatory
networks (used as the input to chapters 3 and 4) from data. Subsequently, I describe
the different biological knowledge sources currently available. Finally, I provide an
overview of existing work in knowledge integration.
2.1 Biological Data
Most biological experiments rely on the central dogma of molecular biology -
the process by which cells control biological processes. Cells store hereditary
information within their nucleus, in the form of strands of deoxyribonucleic acid
(DNA). Strands of DNA are organized into genes - a molecular unit of heredity that
codes for a specific function. While the process by which hereditary instructions are
converted into cellular signals is complex, the core of this conversion occurs through
two key steps called transcription and translation. In eukaryotes, DNA is converted
into messenger ribonucleic acid (or mRNA) through a process called transcription;
and mature mRNA is converted into proteins through a process called translation.
9
Figure 2.1: Biological data and knowledge in the context of a eukaryotic cell.
Green rectangles indicate biological data while blue rectangles indicate biological
knowledge.
Proteins then carry out the different functions required for maintaining the cell.
Since a normal individual contains specified amounts of each protein, variations in
the amounts of proteins across different individuals could shed light on differences
across individuals. As it is relatively easier to gather measurements of mRNA levels
over protein levels, mRNA measurements are used in lieu of proteins. They are
used to provide information about the role of genes (or proteins) within the cell
including their functions, their location, and their relationships with other genes
(or proteins) under different phenotypic conditions. Such measurements are called
gene expression measurements. Traditionally, gene expression measurements are
made by Northern blot experiments. However, recent developments in array-based
technology allows the simultaneous hybridization of mRNA to a large number of
DNA sequences.
Hybridization is usually measured through fluorescence; hence, a typical microarray
experiment results in images which need to be analyzed to identify the arrayed
10
spots and measure relative fluorescences for each element [8]. Raw gene expression
measurements are usually obtained as a ratio of the fluorescences of the target sample
to a control. Continuous gene expression measurements can be discretized to fall
into three categories – up-regulated (when the expression of the target is higher than
the control), down-regulated (when the expression of the target is lower than the
control) and neutral (when the expression of the target equals the control).
Abnormal gene expression could be attributed to several reasons and alterations in the
DNA copy number is one such reason [9]. Comparative genomic hybridization [10]
was the first method developed to measure copy number variations (CNV). Typically,
the total genomic DNA is isolated from both a target and a reference population,
differentially labelled and hybridized to metaphase chromosomes [9]. Recently,
DNA microarrays have been used to achieve comparative genomic hybridization on
a genome-wide scale. CNVs represent alterations of fragments of DNA resulting
in an abnormal number of copies of the same fragment. With around 12 % of the
human genome being susceptible to CNVs [11], CNVs play an important role in
the differences between individuals, and thus, also in determining the biological
mechanisms behind diseases.
Due to variations in equipments and measurement technologies, high-throughput
data is typically pre-processed before any computational analysis. Quackenbush et.
al. provides a review of the methods popularly used to pre-process high-throughput
data [8].
2.2 Inferring Regulatory Networks from High-throughput Data
The large amount of biological data being currently generated has paved the way
for several data-driven methods for inferring regulatory networks from this data
(reviewed in [12, 13, 14]). These methods differ on the basis of the computational
11
definition of a biological interaction. The simplest regulatory model - the Boolean
network represents genes as discrete ON/OFF switches [15, 16] with regulation
modeled as a combination of logical operations. Liang et. al. [17] introduced RE-
VEAL, which uses information-theoretic principles to reduce the search space and
constructs a large-scale Boolean network from data. Following this, several varia-
tions of algorithms [18, 19, 20] have been proposed for inferring Boolean networks
from data. Although Boolean networks provide a simple model for regulation, and
are useful to understand steady states and network robustness, Boolean networks are
known to possess several drawbacks including failing to cope with the dynamics and
uncertainty inherent in biological regulation.
Probabilistic Boolean networks (PBN), introduced by Shmulevich et. al. [21]
incorporates uncertainty and incomplete evidence in the gene regulatory network
model by representing each regulatory relationship with several logical functions,
each of which is associated with a probability based on data. PBNs have been used
in several applications, including constructing a 15 gene sub-network inferred from
human glioma expression data [22, 23]. Bayesian networks [24] represent another
important class of probabilistic graphical models used in modeling gene regulatory
networks and have been extensively applied in genomics [25, 26, 27, 28]. Key
strengths of the Bayesian approach include its ability to handle incomplete data,
avoid over-fitting, infer causal relationships and encode domain knowledge into the
learning framework.
Besides regulatory models, several association-based methods have recently gained
popularity in the inference of gene regulatory networks from data. Correlation
measures are used to capture the strength of association between two genes, and
consequently learn an interaction network [29]. Mutual information is another
popular measure extensively used in learning gene interactions [30, 31, 32, 33].
12
However, while these methods have made progress in providing mechanisms for
learning gene regulatory networks from data, they still fail to cope with the hetero-
geneity inherent in biological data. Several methods have been recently developed
to identify sub-type specific modules from heterogeneous data [33, 34, 35, 36, 37].
COALEASCE [35] integrates both gene expression and sequence data to discover
regulatory motifs. On the other hand, CONEXIC [36] uses genes with copy number
aberrations as putative drivers of gene expression to identify modules. Mukherjee et.
al. [37] have developes a network clustering approach based on the theory of sparse
Gaussian Markov Random Fields, to identify subtypes differing in terms of network
phenotype. The concept of a regulatory module (analogous to a bicluster [38] – a
sub-set of consistently regulated genes within a sub-set of samples or conditions)
was first introduced by Ihmels et. al. [39] who has proposed an algorithm which
uses a set of seed genes to extract tightly regulated transcription modules from
biomedical data. The notion of learning regulatory modules with associated experi-
mental conditions has been introduced by Segal et. al. in module networks [40]. A
module network [41] is a probabilistic model consisting of modules of co-regulated
genes and corresponding regulatory programs. Module networks have been shown
to extract regulatory relationships in several biological applications [42, 43, 44].
Similarly, integrative Bayesian network approaches have also been developed in
order to learn regulatory networks from data [35] as well as identify driver muta-
tions and the biological processes [36]. Context-specific gene regulatory networks
[45, 46] provide a mechanism to learn regulatory relationships between genes using
probabilistic measures of consistency.
While these approaches deal with the heterogeneity of the data, as described in
chapter 1, the size of these data-driven networks tends to be of the order of several
thousand interactions, rendering manual interpretation and biological experimen-
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tation for each interaction nearly impossible. Most existing methods focus on the
evaluation of a few interactions, resulting in a large number of underutilized hypothe-
ses. Table 2.1 shows some of the popular methods for inferring gene regulatory
networks from data and the extent to which the proposed hypotheses (interactions)
have been validated. As seen in the table, the field lacks a systematic approach for
using biological knowledge in determining plausible biological interactions.
2.3 Biological Knowledge
I now describe the different sources of biological knowledge that could be used in
analysis of data-driven networks. Biological knowledge consists of validated facts
about biological processes and is typically either manually curated or automatically
curated and then manually verified.
Gene Ontology
I begin with one of the most popular knowledge sources - the Gene Ontology (GO).
The Gene Ontology(GO) Consortium [4, 5] provides a structured, common, con-
trolled vocabulary for defining the roles of genes and gene products in any organism.
The roles of genes and gene products are organized through three independent
ontologies : biological process, molecular function and cellular component.
An ontology term is categorized as a biological process when it represents a biologi-
cal objective to which a gene or gene product contributes (e.g., ‘translation’); as a
molecular function, when it represents the biochemical activity of a gene product
(e.g., ‘enzyme’) and as a cellular component, when it represents the place in the cell
where the gene product is active (e.g., ‘ribosome’).
The Gene Ontology Annotation (GOA) database [47] provides electronic and manual
14
Table 2.1: Existing approaches for knowledge integration in interpreting data-driven
networks.
Publication Method Dataset Network Scale Knowledge Inte-
gration
Friedman et. al.
(2000)
Bayesian
Networks
Saccharomyces
cerevisiae (76
expression mea-
surements; 6177
ORFs)
800 genes; 250
genes used for
robustness analy-
sis
Literature valida-
tion of few genes
selected by a net-
work property.
Ong et. al.
(2002)
Dynamic
Bayesian
Networks
E.coli, time
series gene
expression data
(12 data points)
169 genes Prior knowledge
through operons.
Literature valida-
tion of a few
genes.
Hartemik et. al.
(2002)
Bayesian
Networks
Saccharomyces
cerevisiae (320
samples)
32 genes + 1 ex-
tra variable
Literature valida-
tion of a few rel-
evant genes.
Lahdesmaki et.
al. (2003)
Boolean net-
works
Saccharomyces
cerevisiae gene
expression
time-series
733 genes; 5
genes studies
Literature valida-
tion of a few rel-
evant genes.
Shmulevich et.
al. (2003)
Probabilistic
Boolean net-
works
Human glioma 15 genes Literature valida-
tion of a few rel-
evant genes.
Lee et. al.
(2006); Li et. al.
(2007)
Module
networks,
Bayesian
likelihood
score
Saccharomyces
cerevisiae (320
samples)
466 candidate
regulators, 2355
genes from gene
expression,
GO, MIPS,
KEGG, TRANS-
FAC
Kim et. al.
(2007); Sen et.
al (2009)
Context-
specific
GRN
Target Now
Data(17085
probes, 146
samples)
1,790 vertices,
9566 edges
Literature valida-
tion of a few rel-
evant genes.
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annotations corresponding to each protein in the UniProt Knowledgebase. A GO
annotation is a specific association between a GO term identifier and a gene or protein
and has a distinct evidence source that supports the association. Each gene product
can be annotated to multiple GO terms at different levels of the GO hierarchy.
Pathway Databases
While the Gene Ontology provides information on the functions and locations of
biomolecules within the cell, often it is useful to integrate knowledge on their
interactions. Biological pathway databases are a popular mechanism for storing in-
formation on interactions between biomolecules. Pathguide [48] lists 298 biological
pathway resources including protein-protein interactions, metabolic pathways, sig-
naling pathways, pathway diagrams, transcription factors, gene regulatory networks,
protein-compound interactions, genetic interaction networks, and protein-sequence
focused resources. This dissertation uses Pathway Commons [6] as well the as
the the pathway component of the Molecular Signature Database (MSigDB) [49].
Pathway Commons consists of nine different pathway databases. Table 2.3 provides
a description of these pathway databases along with the benefits and shortcomings
of each resource.
From 2.3, three main aspects are identified that could limit the application of these
databases to data-driven networks - species and reliability.
In terms of species, most of the databases consist of well-documented yeast interac-
tions. Human interaction databases mainly consist of Cancer Cell Map, HumanCyc,
Human Protein Reference Database and IMID. For the remaining databases the
proportion of human interactions within the total database varies between 10% and
50%. Given the relatively low overlap between human and yeast interactions (both
orthologs and number of interactions), applicability of yeast interactions to validate
16
Ta
bl
e
2.
2:
L
is
to
fp
at
hw
ay
re
so
ur
ce
s
in
Pa
th
w
ay
C
om
m
on
s.
Pa
th
w
ay
R
e-
so
ur
ce
Pr
ot
ei
ns
In
te
ra
ct
io
ns
D
es
cr
ip
tio
n
B
en
efi
ts
(+
)a
nd
Sh
or
tc
om
in
gs
(-
)
B
io
G
ri
d
[5
0]
36
,1
96
19
2,
36
9
pr
ot
ei
n-
pr
ot
ei
n
in
te
ra
ct
io
ns
,
ge
ne
tic
in
te
ra
ct
io
ns
co
ns
ol
id
at
es
in
te
ra
ct
io
ns
fr
om
di
ff
er
en
tm
et
ho
ds
bo
th
ex
pe
ri
m
en
ta
la
nd
co
m
pu
ta
tio
na
l(
+)
;
lit
er
a-
tu
re
so
ur
ce
s
av
ai
la
bl
e
fo
ra
ll
in
te
ra
ct
io
ns
(+
);
hu
-
m
an
in
te
ra
ct
io
ns
co
ns
tit
ut
e
46
%
of
to
ta
l(
-)
;h
ig
h-
th
ro
ug
hp
ut
in
te
ra
ct
io
ns
(≈
60
%
of
to
ta
l)
co
ul
d
be
un
re
lia
bl
e
(-
)
C
an
ce
r
C
el
l
M
ap
[5
1]
1,
24
5
2,
10
4
pr
ot
ei
n-
pr
ot
ei
n
in
te
ra
ct
io
ns
,
si
gn
al
in
g
pa
th
w
ay
s
m
os
tly
hu
m
an
in
te
ra
ct
io
ns
(+
);
la
rg
el
y
in
vi
vo
,
in
vi
tr
o
w
ith
fe
w
ye
as
t-
2-
hy
br
id
in
te
ra
ct
io
ns
(+
);
ca
nc
er
-s
pe
ci
fic
(+
);
ce
llu
la
rl
oc
at
io
n
av
ai
la
bl
e
(+
);
sm
al
ld
at
ab
as
e
(-
)
H
um
an
C
yc
[5
2]
3,
99
9
5,
27
0
m
et
ab
ol
ic
pa
th
w
ay
s,
si
gn
al
-
in
g
pa
th
w
ay
s
hu
m
an
in
te
ra
ct
io
ns
(+
);
cu
ra
tio
n
le
ve
lf
or
hu
m
an
in
te
ra
ct
io
ns
is
lim
ite
d
(-
)
IM
ID
[5
3]
1,
66
9
1,
72
9
ne
ur
on
al
si
gn
al
in
g
hu
m
an
in
te
ra
ct
io
ns
(+
);
in
te
ra
ct
io
n
ty
pe
la
ck
s
de
-
ta
il
(-
);
sm
al
l
da
ta
ba
se
(-
);
sp
ec
ifi
c
to
ne
ur
on
al
si
gn
al
in
g
(-
)
H
um
an
Pr
o-
te
in
R
ef
er
en
ce
D
at
ab
as
e
[5
4]
9,
87
1
40
,6
18
pr
ot
ei
n-
pr
ot
ei
n
in
te
ra
ct
io
ns
,
co
m
pl
ex
es
,p
os
t-
tr
an
sl
at
io
na
l
m
od
ifi
ca
tio
ns
in
vi
vo
,
in
vi
tr
o
an
d
ye
as
t-
2-
hy
br
id
in
te
ra
ct
io
ns
(+
);
bo
th
di
re
ct
an
d
co
m
pl
ex
in
te
ra
ct
io
ns
(+
);
la
rg
e
nu
m
be
ro
fl
ite
ra
tu
re
ci
ta
tio
ns
(+
);
in
te
ra
ct
io
n
ty
pe
la
ck
s
ex
pe
ri
m
en
ta
ld
et
ai
ls
(-
);
la
rg
e
ov
er
la
p
w
ith
ot
he
rd
at
ab
as
es
(-
)
17
In
tA
ct
[5
5]
13
2,
80
6
15
7,
34
4
pr
ot
ei
n-
pr
ot
ei
n
in
te
ra
c-
tio
ns
de
ta
ile
d
ex
pe
ri
m
en
ta
lm
et
ho
ds
(+
);
hu
m
an
in
-
te
ra
ct
io
ns
on
ly
20
%
of
to
ta
l(
-)
M
IN
T
[5
6]
92
,8
66
12
1,
82
4
pr
ot
ei
n-
pr
ot
ei
n
in
te
ra
c-
tio
ns
di
re
ct
an
d
in
di
re
ct
in
te
ra
ct
io
ns
(+
);
in
te
ra
c-
tio
ns
fr
om
se
ve
ra
ld
et
ec
tio
n
m
et
ho
ds
(+
);
hu
-
m
an
in
te
ra
ct
io
ns
on
ly
≈2
5
%
of
to
ta
l(
-)
;h
ig
h-
th
ro
ug
hp
ut
in
te
ra
ct
io
ns
(≈
80
%
)c
ou
ld
be
un
-
re
lia
bl
e
(-
)
N
C
I/
N
at
ur
e
Pa
th
w
ay
In
te
ra
ct
io
n
D
at
ab
as
e
[5
7]
6,
18
6
13
,8
79
si
gn
al
in
g
pa
th
w
ay
s,
pr
ot
ei
n-
pr
ot
ei
n
in
te
ra
c-
tio
ns
ca
nc
er
-s
pe
ci
fic
(+
);
ev
id
en
ce
co
de
s
(+
)
R
ea
ct
om
e
[5
8]
9,
00
3
6,
13
9
m
et
ab
ol
ic
pa
th
w
ay
s,
si
g-
na
lin
g
pa
th
w
ay
s
cu
ra
te
s
pr
oc
es
se
s
w
ith
se
ve
ra
l
le
ve
ls
of
de
-
ta
il
(+
);
cu
ra
te
d
m
an
ua
lly
by
pe
er
-r
ev
ie
w
(+
);
is
of
or
m
-s
pe
ci
fic
(+
);
hu
m
an
re
ac
tio
ns
fo
rm
on
ly
≈
10
%
of
to
ta
l(
-)
18
interactions from human datasets is limited. Further differences include the total pos-
sible interactions in each of the species. For instance, the full yeast protein-protein
interaction network contain 37,800-75,500 interactions and the full human network
154,000-369,000, but owing to a high false-positive rate, maps (as of 2006) are
roughly only 50% and 10% complete, respectively [59]. Thus, in this dissertation, a
sub-set of the database corresponding to human interactions alone was used.
In terms of reliability, interactions within the databases are obtained using several
sources - biological experimentation including yeast two-hybrid (Y2H) experiments,
tandem affinity purification, as well as computational methods. In general, the
interactions which have been verified through manual biological experimentation are
known to be more reliable than data-driven interactions. However, even amongst the
biological interactions, interactions derived using high-throughput methods such as
Y2H screening are characterized by a large number of false positives. For instance,
the reliability of Y2H screening mechanisms has been shown to be ≈ 50 % [60]
using cellular localization and cellular role properties. Amongst the databases,
both MINT and BioGrid contain a large proportion of high-throughput interactions
(explicitly specified), while Cancer Cell Map and the Human Protein Reference
Database contain interactions verified by Y2H screening, which again could be
unreliable. However, in this dissertation, interactions were not filtered based on the
reliability of the experimental detection method, instead, reliability (through the
number of publication counts) is used to weight interactions, since the number of
human interactions currently available for use is already limited.
Finally, it is also important to acknowledge the multiple types of interactions within
the databases. Methods for the inference of biological interactions from high-
throughput data usually derive co-expression based interactions. Such interactions
could be attributed to multiple reasons, including protein-protein interactions as well
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as transcription factors or regulatory interactions. While this dissertation focuses on
protein-protein interactions as a possible explanation, multiple other explanations
are possible (including transcription factors) and are beyond the scope of this work.
Chromosomal Location
Genes which are located close to one another tend to share functions making chro-
mosomal location a useful resource for understanding the role of genes within the
cell. Chromosomal location information was extracted from the Molecular Signa-
tures Database (MSigDB) [49]. Such information is helpful in identifying effects
pertaining to chromosomal amplifications or deletions, and epigenetic silencing. For
instance, cytogenetic abnormalities have been attributed to diseases such as leukemia
[61]. Similarly, chromosomal location is particularly appropriate in the context of
copy number variations.
Drug Databases
Finally, one of the important aspects of understanding the biology behind disease is
understanding the role of therapeutic agents. To this end, the publicly available drug
database Drugbank [62] is used. Drugbank is a publicly available database consisting
of information on the nomenclature, ontology, chemistry, structure, function, action,
pharmacology, pharmacokinetics, metabolism and pharmaceutical properties of both
small molecule and large molecule drugs, along with target diseases, proteins, genes
and organisms on which these drugs act. Layering drug information allows for the
ability to identify drug targets from the data.
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2.4 Techniques for Knowledge Integration
I now describe the techniques which use these knowledge sources in the analysis of
data-driven hypotheses. The methods can be broadly categorized on the basis of the
data-driven hypotheses they use as input.
The first category of techniques is devoted to the annotation of interesting gene
lists (results from the analysis of a high throughput dataset) with relevant biological
processes. The key characteristic of gene set annotation approaches is that knowledge
is usually used in the form of gene sets. Such methods [63, 64, 65, 66, 67, 49, 68,
66, 67, 49, 69] tend to use statistical hypothesis testing in the extraction of relevant
biological functions. Typically, the output takes the form of a list of overrepresented
biological functions. However, such methods have limited application as they can be
applied to simply gene lists, where the connectivity between the genes is ignored.
The second category of techniques focuses on data-driven networks and are relatively
few in number. In most cases, manual verification is still used, as shown in Table
2.1. Manual verification has been used in validating Bayesian networks learnt from
yeast [70], mutual-information based networks derived from human B cells [32],
in analyzing relevance networks learnt from cancer cell lines [31] and in validating
context-specific networks learnt from both a melanoma dataset [45] and a refractory
cancer dataset [46]. However, manually extracting relevant supporting literature for
the validation of networks derived from high-throughput data is cumbersome. Fur-
ther, given the scale of the data-driven networks, only a small number of interactions
can be manually validated, even though validating the entire network could yield
several novel hypotheses on biological interactions.
In contrast, a few systems have been developed for the automatic validation of data-
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driven hypotheses. For example, Bayesian networks derived from yeast have been
validated using the Kyoto Encyclopedia of Genes and Genomes (KEGG) [71]. Bader
et. al. [72] have compared data-driven interaction networks against experimentally-
derived networks using a global approach. However, most data-driven networks
learnt from high-throughput data require validation at a finer level of granularity
as validation is with the view of prioritizing interactions for further experimental
verification. To achieve this, Hanalyzer [73] builds knowledge networks based upon
multiple sources of interaction evidence (e.g., protein-protein interaction databases)
and uses a noisy-OR approach to validate networks derived from experimental
data against knowledge networks. Interactions are then scored based on available
knowledge and thus, Hanalyzer facilitates the development of novel hypotheses using
the combined analysis of knowledge and data, though applications are currently
limited to mice.
Techniques devised for yeast and mice are not always applicable to humans as
described in the previous section. Additionally, one of the main characteristics of
data-driven interactions is that they capture associational relationships – thus the
underlying biological interactions that they map onto could be a single interaction or
in most cases, a series of interactions.
2.5 Summary
Thus, this chapter provides the background required for the rest of this dissertation. I
have described the different kinds of biomedical data used, the methods used to infer
regulatory networks from this data, limitations of these methods, biological knowl-
edge sources and approaches for using biological knowledge in the interpretation of
data-driven hypotheses. In the next chapter, I move to the approach developed for
validating data-driven networks at the individual interaction level of granularity.
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Chapter 3
EVALUATING INDIVIDUAL INTERACTIONS
One of the first steps in understanding data-driven interactions is understanding how
they map on to known biological pathways. As described in Chapter 2, existing
methods for automatically scoring data-driven interactions using biological knowl-
edge are few. Here I discuss the motivation for scoring data-driven interactions,
relevant work in this area, the methodology developed in this dissertation and its
application to data-driven networks inferred from gene expression data for cancer
patients.
3.1 Motivation
Data-driven interactions provide a mechanism to hypothesize regulatory interactions
that occur in a specific experimental condition, reflected in the data. However,
not all data-driven interactions necessarily correspond to regulatory interactions
due to the presence of experimental noise within the data. Instead, data-driven
interactions can comprise three types of interactions – known biological interactions,
novel biological interactions and false interactions. Consequently, it is necessary to
identify these three categories within the data-driven network to effectively utilize
these interactions.
Mapping data-driven interactions to known biological interactions allows a biologist
to associate the network with a measure of credibility. For instance, when faced
with needing to choose between two data-driven networks, the one which has a
higher number of edges with reliable explanations would be more likely to augment
biological knowledge than the one with fewer edges having less reliable explanations.
This measure serves as an indication to how well the network is able to capture
23
biological interactions which are already known.
However, the true contributions of data-driven networks stem from their ability to
hypothesize novel interactions. Hence, a second scoring metric is developed which
assigns to each edge the likelihood of that edge being a novel biological interaction.
High-scoring interactions subsequently serve as candidate hypotheses for wet-lab
experimentation.
3.2 Relevant Work
While Chapter 2 provides an overview of the approaches which motivated this
dissertation, here I focus on literature relevant to scoring biological interactions.
Most existing literature is devoted to protein-protein interactions and could be
categorized into two – methods which score individual protein-protein interactions
and methods for extracting pathway structures from protein interactions.
Scoring protein-protein interactions is usually achieved using either biological knowl-
edge or network properties or both. Several kinds of biological knowledge are used
for scoring interactions including protein structure information [74], GO annota-
tions [74], expression information [75], sequence homology [74] and the existence
of paralog interactions [75]. Methods that use network properties can be categorized
based on whether they use local properties, global properties or both. Examples of
local properties include proportions of shared neighbors [76, 77] and the extent to
which a candidate interaction’s neighbors are connected [78]. On the contrary, Saito
et. al. [79] propose a global approach to rank interactions by classifying interactions
into specific categories and using the proportions of interactions in each category
to assign reliability scores. Both local and global properties have been combined
and used by Liu et. al. [80]. Additionally, methods have also used shortest-path
approaches [81] as well as Bayesian evidence combination in determining the
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reliability of interactions [82].
A few automatic systems have been developed for the the inference of regulatory
pathways from protein-protein interaction networks. For instance, Herrga˚rd et.
al. [83] have evaluated data-driven measurements (not necessarily interactions)
in Escherischia coli and yeast, using metrics designed to measure the consistency
between expression measurements and literature-derived interactions. Similarly,
NetSearch [84] has been developed to enumerate and rank linear pathways using
gene expression profiles of pathway members. Extending this concept to higher order
structures (trees and parallel paths), Scott. et. al. [85] have developed a color-coding
technique to identify pathways within protein interaction networks. This has been
extended to generalized sub-structures by Lu. et. al. [86] using a randomized divide-
and-conquer scheme. PathFinder [87] uses a combination of knowledge integration
and association rule mining to elucidate pathways from protein interactions. Finally,
Gitter et. al. [88] develop a method to elucidate pathways from protein interaction
networks by formulating the problem as an edge orientation problem and focusing
on directionality as an important aspect of pathways.
While the approaches developed for protein interaction networks are comparable,
such approaches cannot be directly applied to data-driven networks. Protein-protein
interactions are the results of direct measurements of protein concentrations, whereas,
gene expression is measured at the mRNA level (described in Chapter 2). Hence,
data-driven networks inferred from gene expression data tend to represent associ-
ational relationships, which could correspond to a direct relationship between the
genes (and/or proteins) or, as in most cases, an indirect relationship between the
genes (and/or proteins) involved.
In this dissertation, I develop a method to map data-driven interactions onto literature-
derived pathways and subsequently score the unmapped interactions using other
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biological knowledge sources. The methods developed in this chapter make sev-
eral contributions to the analysis of data-driven interactions. Firstly, the methods
developed here allow for direct interpretation of the data-driven interactions that
do map onto biological knowledge. Secondly, the reliability of literature-derived
pathways is taken into account while mapping data-driven edges. Thirdly, the scoring
method for unmapped interactions allows for the extraction of the best candidate
hypotheses from the data-driven interactions which could be validated with wet-lab
experiments. Finally, these methods allow for comparisons between different kinds
of data-driven networks to determine which one is better at identifying biologically
plausible hypotheses.
3.3 Problem Formulation
In this section, I mathematically formulate the problem of assessing data-driven
interactions using existing knowledge. Let the data-driven network be represented
as Gd = (Vd,Ed) where Vd is the set of genes within the network, Ed is the set of
interactions between these genes and associated with each edge is a non-negative
edge-weight wg : Ed → R+ denoting the strength of relationship between the two
genes.
Let biological knowledge be represented in the two forms
(a) biological pathways represented as a network Gb = (Vb,Eb) where Vb is the set
of genes within the network, Eb is the set of interactions between these genes
and associated with each edge (ub,vb) is a set of distinct literature citations
C(ub,vb) = {c1uv,c2uv, · · ·cmuv} that report the interaction and,
(b) functional annotations T (u)= {t1, t2, · · · tr}, a set of functional terms or pathways
associated with the gene u.
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The goal of this work is to identify for every edge (ud,vd) ∈ Ed ,
1. when there is a mapping of the edge to literature-derived pathways, the score
α → R+ quantifying the extent to which the edge could be reliably mapped
onto existing literature-derived pathways, and
2. when there is no mapping of the edge to literature-derived pathways, β →
[0,1], a score quantifying the extent to which the edge is likely to be a novel
biological interaction.
3.4 Identifying Biological Explanations
The first step in assessing data-driven interactions is understanding how they map
onto literature-verified pathways [89].
Methodology
Literature-derived pathways are composed of different interactions, each of which
could be reliable based on the extent to which it has been studied and experimentally
validated. Hence, I first need to define what a reliable interaction is in a literature-
derived pathway [89]. As described above, each literature-derived edge (ub,vb) is
associated with a set of distinct literature citations C(ub,vb) = {c1uv,c2uv, · · ·cmuv} that
report the interaction. The higher the number of citations, the more reliable an
interaction is as it implies that several independent groups have been successful in
experimentally confirming the interaction.
Definition 1 (Citation Weight). The citation weight, w(ub,vb) is the reliability
associated with a single literature-derived interaction.
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Given an edge (ub,vb), with distinct literature citations C(ub,vb) = {c1uv,c2uv, · · ·cmuv},
where m = |C(ub,vb)| the citation weight is defined as
w(ub,vb) =

4 if m = 0
2 if m = 1
1
log2(m)
otherwise
(3.1)
Using equation 3.1, interactions with lower values of w(ub,vb) are more reliable
and interactions with higher values of w(ub,vb) are less reliable. When m is greater
than 1, I take the log-transform to appropriately scale larger number of citations, as
after reaching a certain number of citations, more evidence is not necessarily better.
When m = 1, I assign a weight of 2 to indicate this is equivalent to being half as
good as an interaction with 2 citations and similarly assign a weight of 4 for the case
when m = 0.
After reliability values have been assigned to every edge within the literature-derived
network Gb = (Vb,Eb), Djikstra’s shortest-path algorithm [90] is applied to every
edge within the data-driven network Gd = (Vd,Ed).
Definition 2 (Literature Path Reliability). The literature path reliability, α is
the reliability associated with the literature path corresponding to a data-driven
interaction (ud,vd). This is computed as
α =
 ∑(a,b)∈S w(a,b) when S 6= /0inf when S = /0 (3.2)
where S is the set of edges in the shortest-path connecting ud with vd in Gb. The
distribution of α is useful in comparing different data-driven networks and the
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following sub-section examines how data-driven networks of a biological data set
evaluate against literature-derived pathways.
Application: Glioblastoma Multiforme (TCGA)
In order to demonstrate the application of the methods developed in this chapter, I
used the Cancer Genome Atlas (TCGA) - Glioblastoma Multiforme (GBM) data
[91]. 301 samples were extracted from the TCGA Portal after screening out samples
from cell lines and replicates. 10 normal samples were used as the reference to
convert GBM expression values to z-score values by comparing the expression
values from GBM samples to the distribution of normal samples. Genes with a low
variance across the tumors were filtered out leaving a total of 4166 genes.
While Chapter 2 discusses several existing methods for inferring data-driven net-
works, in this chapter, I choose three of the algorithms as representatives of three
classes of methods – Bayesian networks (directed, probabilistic), ARACNE (undi-
rected, mutual information based) and context-specific networks (directed, incorpo-
rates context-specificity).
In the case of the Bayesian networks and the context-specific networks, the ex-
pression data was quantized into one of three discretized values (+1,0,−1) by
thresholding the z-score at 1.65 corresponding to 95% significance, while in the case
of ARACNE, the continuous values were used as is.
Bayesian Networks : I use the Bayesian networks learnt using the algorithm BANJO,
an algorithm which uses a structured iterative learning strategy to find the best
possible network given an initial network [92]. The Java implementation on BANJO
2.0 [92] was used to learn the Bayesian network after discretizing the transformed
data to three levels. BANJO uses simulated annealing to heuristically search for
initial networks. A posterior averaged weighted ‘consensus’ network was generated.
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Context Specific Networks : Context specific gene regulatory networks used here are
learnt from gene expression data using the cellular context mining algorithm [46].
Unlike conventional gene regulatory networks, edges in context-specific GRNs rep-
resent the interaction conditioned on a subset of samples, i.e. their biological context,
thus lending adaptability to the model of biological regulation. The parameters for
learning the network were set at a maximum crosstalk of 0.3, conditioning of 0.1
and a corrected p-value of 0.05 for extracting context motifs. Subsequently the
context-specific gene regulatory network was created using a statistical significance
threshold of a corrected p-value of 0.005.
ARACNE : I use the ARACNE algorithm [32] to learn gene regulatory networks.
ARACNE learns biological networks from high-throughput data using mutual infor-
mation between pairs of genes to estimate the strength of the relationship between
every pair of genes. ARACNE was also applied to this data using the recommended
parameters – a Data Processing Inequality (DPI) threshold of 0.15, a significance p-
value of 1×e−7 along with a mutual information threshold of 0.65. Since ARACNE
produces an undirected network, the edges yielded by ARACNE were converted
to directed edges; for instance an undirected edge (u,v) would correspond to the
directed edges (u,v) and (v,u).
Statistical parameters in all three cases were set to obtain a similar number of
interactions in all three networks.
Comparing Data-driven Networks Against Literature-derived Pathways
The first set of experiments was to compare how well the data-driven networks
constructed from three different algorithms are supported by existing literature-
derived pathways. The pathway resources discussed in Chapter 2 were used as a
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repository for literature-derived pathways. the shortest-path algorithm was applied
to all three networks and the distribution of scores (α) is shown in Table 3.1.
Table 3.1: Evaluating data-driven networks against literature (GBM). The table
indicates the number of total annotated edges from the TCGA GBM networks as
well as the distribution of the edges across α in comparisons against literature-
validated interactions. The total number of annotated edges was computed as the
number of edges of the network where both vertices existed in the literature-derived
database.
Category ARACNE Bayesian Context
Mining
Total Annotated Edges 4154 3051 6157
α = inf 26.6% 28.7% 39.8%
0≤ α < 2 13.7% 5.2% 1.9%
2≤ α < 4 27.5% 24.1% 17.6%
4≤ α < 6 23.5% 30.3% 28.9%
6≤ α < 8 7.7% 10.0% 9.8%
8≤ α 1.0% 1.7% 2.1%
Table 3.1 shows the results obtained from evaluating the three networks using
literature-derived pathways. From this table it is interesting to see that, with networks
of the order of ≈ 3000-6000 genes, all three networks have similar proportions of
evaluated interactions. Additionally the median α value, excluding α = inf, was
found to be 3.69 in the case of ARACNE, 4.42 in the case of the Bayesian network
and 4.7 in the case of the context-specific network. Using these statistics we note
that ARACNE has the largest portion of mapped interactions while context-specific
networks have the smallest portion of mapped interactions.
Comparing Data-driven Networks Against Random Networks
An interesting question is to understand whether these statistics are random. Specifi-
cally, if I had a random network with the same nodes as the data-driven network but
a different topology, how would this network evaluate against a biological network
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? To achieve this, random networks were generated corresponding to each of the
three networks by maintaining the connectivity of each network but re-shuffling
the node identifiers (gene names) in each case. Figure 3.4 shows how the three
networks compare against random networks in terms of the proportion of edges with
literature-derived paths. It is interesting to note that these random networks have
similar proportions of literature-validated paths. Figure 3.4 shows the distribution
of α across the data-driven networks and the random networks. Again, interest-
ingly, random networks have similar median α scores when compared to data-driven
networks.
Figure 3.1: Comparing proportions of interactions with literature-verified paths
against random networks generated across 1000 permutations. Green dots indicate
the proportion of interactions with a literature-verified path.
These performances could be attributed to either the utility of existing data-driven
networks, properties of biological networks or, the incompleteness of biological
knowledge.
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Figure 3.2: Comparing amount of literature evidence (α) for random networks
against data-driven networks. Green dots indicate the median values of α for the
TCGA data-driven networks.
Number of Knowledge Sources Required for Validation
Finally, I also looked into the number of distinct databases that composed the
literature-derived paths corresponding to each data-driven interaction. I observed
that, of the edges that were validated, 77.1 % in the case of ARACNE, 84.7 % in the
case of the context-specific network and 82.6 % in the case of the Bayesian network
required a combination of more than one knowledge source for their evaluation. This
indicates that the integration of multiple sources is vital in such validation efforts.
Although evaluation of the data-driven interactions is insightful in determining
whether the data-driven interactions are useful, plausible novel hypotheses tend to be
those data-driven interactions which cannot be explained by literature-derived paths.
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Hence, I now proceed to assess the data-driven interactions using other knowledge
sources.
3.5 Assessing Data-driven Interactions
Data-driven interactions which do not map onto existing literature-verified pathways
are ideal candidates for possible novel hypotheses. However, prior to wet-lab
experimentation it is critical to determine which of the interactions are plausible
hypotheses and which ones are likely to be false discoveries.
Methodology
Given a data-driven interaction (ud,vd), several factors contribute to whether the
interaction is a true biological interaction, including both network properties (such
as the connectivity or topology) as well as functional annotations. In this scoring
scheme, the likelihood of an interaction between the nodes connected by a data-
driven edge, is computed as a combination of several factors. While I specifically
address four specific factors, additional evidence could be easily incorporated, if
desired.
The first factor I consider is the overlap in neighborhood of the two nodes. The
intuition behind this, is that as biological networks tend to be small-world [93],
interacting partners with a high overlap in existing neighbors would be more likely to
interact than others. This measure takes into account the topology of the data-driven
network.
Definition 3 (Neighbor Overlap). The neighbor overlap, O(ud,vd) represents the
combined likelihood of the shared neighbors between the nodes ud and vd , to interact
with another node.
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Given an interaction (ud,vd) with Nud and Nvd neighbors respectively, the neighbor
overlap is computed as
O(ud,vd) = 1− ∏
i∈(Nud∩Nvd )
(1−ai) (3.3)
where ai represents the node interaction probability, as described below. The node
interaction probability represents a normalized measure of how likely each node
is to have another interaction and derives inspiration from the HITS algorithm
for identifying authoritative nodes in social networks [94]. The node interaction
probabilities are computed by an iterative procedure (Algorithm 1), where in
each iteration the node interaction probabilities for each node are updated based
on the degree of the node and the node interaction probabilities of its immediate
neighbors. Normalizing the node interaction probabilities at each stage ensures
convergence. When the algorithm converges, each node is assigned a score which
denotes how likely it is to have an interaction, using the logic that nodes with
more connections are more likely to have an additional connection relative to nodes
with fewer connections. However, this score is computed relative to the nodes in
a network and hence depends on the size of the network. To ensure the ability to
compare node interaction probabilities across networks of different sizes, the last
transformation (lines 18-20) is made using the density of the network assuming an
undirected network. As the interaction likelihood of a given node is relative to the
rest of the network, the neighbor overlap O thus considers both local properties of
the interacting partners as well as global network properties.
Next, I consider the knowledge overlap between the two interacting partners com-
puted using biological annotations of each of the interacting partners. Biological
annotations usually tend to represent the functions or biological properties associated
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Algorithm 1 Computing the Node Interaction Probabilities
1: Input : G = (V,E)
2: Output : A = a1,a2, · · ·a|V |
3: for all i ∈V do
4: ai = 1
5: end for
6: A′ = 0
7: while (A−A′)2 > 0 do
8: A′ = A
9: for all v ∈V do
10: for all u : ((u,v) ∈ E ‖ (v,u) ∈ E) do
11: av = av+au
12: end for
13: end for
14: for all v ∈V do
15: av = av√
∑i∈V a2i
16: end for
17: end while
18: for all v ∈V do
19: av = av
√
(|E|/(|V |2)
20: end for
with genes, and are a useful source of evidence as interacting genes usually tend to
share common annotations. However, as the scoring method is designed to iden-
tify potential novel interactions, it is relatively less likely to find shared biological
annotations amongst the two nodes in isolation, and it is important to look at their
neighborhoods.
I now define the neighborhood for the nodes participating in a data-driven interaction.
For a given data-driven interaction (ud,vd), let (u1d,u
2
d, · · ·u jd) be the set of first-
degree neighbors of ud and (v1d,v
2
d, · · ·vld) be the set of first-degree neighbors of
vd . Let the neighborhood of ud be defined as the set ud ∪ (u1d,u2d, · · ·u jd) and the
neighborhood of vd be the set vd ∪ (v1d,v2d, · · ·vld). While in theory, it is possible to
expand and look at the neighbors of the neighbors and so on, in this dissertation I limit
the computation to the immediate neighbors. Each node within this neighborhood is
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associated with a set of biological annotations (such as GO terms or pathways).
Definition 4 (Knowledge Overlap). The knowledge overlap, K(ud,vd) represents
the combined enrichment of the shared annotations between the nodes ud and vd .
If T (ud) and T (vd) are the sets of annotation terms associated with the two neigh-
borhoods respectively, I am interested in the terms which are common to both
neighborhoods T (ud,vd) = T (ud)∩ T (vd). Let T (ud,vd) = {t1, t2, · · · tr} be the
terms common to both neighborhoods. Also let { f u1 , f u2 , · · · f ur } and { f v1 , f v2 , · · · f vr }
be the frequencies of the terms within the two neighborhoods.
The knowledge overlap is computed as
K(ud,vd) = 1−
r
∏
i=1
(1−
√
f ui
( j+1)
· f
v
i
(l+1)
) (3.4)
where ( j+ 1) and (l+ 1) are the sizes of the two neighborhoods of ud and vd re-
spectively. The term frequencies for each neighborhood are normalized by the total
number of nodes within the neighborhood in order to make the two frequencies
comparable. The geometric mean of the two term frequencies is considered as a
means to quantify the extent to which the term is present in both nodes. Equation
3.4 was formulated in order to capture the property that having a single overlapping
annotation between the neighborhoods is much more important than having no over-
lapping annotations. However as the number of overlapping annotations increases,
additional annotations are important only to the extent in which they are represented
within each neighborhoods. Hence, annotations which are over-represented within
the neighborhoods would dominate the score.
The knowledge overlap is computed for each biological knowledge source (such as
GO annotations, pathways, chromosomal locations) separately.
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Definition 5 (Interaction Likelihood). The interaction likelihood (β ) of a data-
driven interaction (ud,vd) represents the extent to which the interaction is likely to
be a biological interaction.
Given the neighbor overlap (O(ud,vd)) and knowledge overlap (Ki(ud,vd)) computed
for j different evidence sources, the interaction likelihood of an edge (ud,vd) is
computed as
β = 1− p
√√√√((1−O(ud,vd))p ∗ j∏
i=1
(1−Ki(ud,vd))p) (3.5)
The formulation is such that it can be easily extended to additional sources of
evidence on the interaction between the two. Again, the noisy-OR combination
function is used in order to allow scoring components with larger values to dominate
the overall sore. In this work, the GO database (of December 2011) along with
pathway and chromosomal location information (from the MSigDB database version
3.0) are used as sources of evidence. The GO annotations were filtered based on
evidence codes to include only the experimentally verified annotations.
Performance on Gold Standard : Literature-verified Pathways
One of the first challenges in developing a scoring method for distinguishing true
data-driven interactions from false positives is in determining if the scoring method
is doing what it is supposed to do i.e., assigning high scores to true biological
interactions and low scores to false interactions. To achieve this, the first experiment
studied the performance of the scoring algorithm on literature-verified interactions
from Pathway Commons (illustrated in figure 3.5). Specifically, human interactions
with at least two literature citations were used (in order to eliminate unreliable
interactions from the gold standard). As negative examples, 10000 random pairs of
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nodes (with no path between them in Pathway Commons) were considered (case 1 in
figure 3.5). Using this, the interaction likelihood of each interaction was computed.
Also, the pathway knowledge source was not used in the simulations (however, it
was used in the application study) in order to avoid biases. Three parameters were
varied – p, the power to which each term is raised in the Noisy-OR formulation in
3.5, the threshold for the interaction likelihood to determine if an edge is true or not,
and the proportion of positive examples within the sampled data set. Precision and
recall values were computed at each data point and the results obtained are shown in
figure 3.3. As seen in the figure, in all cases, the scoring method developed in this
work is able to assign appropriate scores.
Figure 3.3: Precision-recall curve using literature-derived interactions.
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Performance on Simulated Data-driven Interactions
The next challenge was in determining if the scoring algorithm performed well in
the context of simulated data-driven interactions. While the ”gold standard” from
Pathway Commons was a good way to determine how well the scoring algorithm
performed, it still did not capture all properties of data-driven interactions. For
instance, data-driven interactions tend to measure associations which could be either
a direct biological interaction or a path of multiple biological interactions. Hence, in
order to study the performance of the scoring algorithm on data-driven interactions,
I simulated interactions as shown in figure 3.5. Specifically, I sampled 10,000
random pairs of nodes from the previously discussed gold standard database (case
2 in figure 3.5). For each such pair, I ensured that the two nodes were connected
(by a path of one or more steps) thus simulating a data-driven interaction. The
interaction likelihood was applied to these simulated data-driven interactions and the
precision-recall values were computed by varying the parameters as before. As seen
in figure 3.4, performance degrades with larger proportions of negative examples
(interactions with no path). However, as seen in 3.1, this is seldom the case while
using data-driven networks.
Performance on Simulated Data-driven Interactions - Incomplete Topology
As discussed in Chapter 2, current estimates of human protein-protein interactions
are incomplete. Hence, an important consideration in designing algorithms which
utilize such knowledge is to ensure the algorithm copes with incomplete biological
knowledge. The next experiment was designed in order to simulate incompleteness
in biological knowledge in the form of interactions that are currently not yet dis-
covered. To achieve this, for each of 10,000 random pairs (with a path) considered
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Figure 3.4: Precision-recall curve using simulated data-driven interactions.
in the previous study, the two nodes were forcibly disconnected. The interaction
likelihood was computed after disconnection and precision-recall values were com-
puted by varying the parameters as before. As seen in figure ??, although there is a
degradation in performance, it is not very significant.
Performance on Simulated Data-driven Interactions - Incomplete Annotations
In order to further understand how the scoring algorithm performs in light of incom-
plete biological knowledge, I also studied the effects of incomplete annotations on
the interaction likelihood. To achieve this, for each knowledge source, annotations
were randomly sampled at 100%, 75%, 50% and 25% as shown in figure 3.7. The
interaction likelihood was computed in each case and precision-recall values were
computed by varying all parameters as before, except the proportion of positive
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Figure 3.5: Simulating data-driven interactions and incomplete knowledge (topol-
ogy).
examples which was set to 60% (the lowest observed using data-driven networks).
As seen in figures 3.8, 3.9, and 3.10, in all cases there is hardly any degradation
in performance, proving that the interaction likelihood copes well with the lack of
biological knowledge.
Application to Data-Driven Interactions in GBM
Finally, I examine the interaction likelihoods of the three data-driven networks.
Figure 3.11 shows the cumulative distribution of the interaction likelihoods with
and without literature-derived paths. Overall, the bayesian network has much lower
scores than Aracne or the context-specific network. Further it is interesting to note
that although 25 – 40 % of the data-driven interactions did not have literature support,
they can be explained through other biological sources. High-scoring interactions
could then be extracted and used for further wet-lab verification.
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Figure 3.6: Performance of scoring algorithm with incomplete knowledge (topol-
ogy).
3.6 Summary
In summary, I have proposed a method for both evaluating and scoring data-driven
interactions using biological knowledge. I have shown how the evaluation of the
data-driven networks could shed light on several interesting properties of biological
networks. For a given network size, the proportion of data-driven interactions
evaluated against literature-derived pathways is similar across networks learnt using
different methods. It is also interesting to note that random networks created using
the same set of nodes as the data-driven network results in comparable statistics.
Further I also find that the integration of multiple knowledge sources plays an
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Figure 3.7: Simulating incomplete biological knowledge in the form of missing
annotations.
important role in such validation efforts.
I have proposed a scoring method for assessing the likelihood of a data-driven
interaction. This metric copes with both incompleteness in biological annotations
as well as missing connections in literature-derived pathways. The interaction
likelihood has then been applied to score the data-driven networks from a glioma
dataset and identify plausible novel hypotheses.
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Figure 3.8: Effects of missing GO biological process annotations on scoring perfor-
mance.
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Figure 3.9: Effects of missing GO molecular function annotations on scoring perfor-
mance.
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Figure 3.10: Effects of missing chromosomal location annotations on scoring perfor-
mance.
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Figure 3.11: Cumulative distributions of interaction likelihood for the data-driven
interactions.
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Chapter 4
IDENTIFYING FUNCTIONAL MODULES
In the previous chapter, I have proposed a method to evaluate data-driven interactions
using existing biological knowledge, along with applications to the data-driven
networks from gene expression data derived from cancer patients. However, often
biologists are faced with the problem of selecting a sub-set of interactions to focus on.
A functional module is a distinct entity consisting of a set of molecular interactions
working towards a common biological purpose, separable from the purposes of
other modules [7, 95]. Here I discuss the motivation for identifying functional
modules within a data-driven network, relevant work in this area, the methodology
developed in this dissertation and the functional modules identified in cancer data-
driven networks.
4.1 Motivation
Within the cell, functional modules play an important role in facilitating evolu-
tion [96, 7, 97]. They represent core biological processes which are robust to
change. During evolution, changes to the ways in which functional modules are
interconnected with one another occurs, leading to different phenotypes, adapted
over time. Hence, identifying functional modules within a data-driven network
enables understanding the cell’s response to external signals [40] under different
phenotypic conditions. For instance, the PI3K/AKT pathway is a functional module
regulating cellular growth within normal cells. Within tumor cells however, several
genes within the PI3K pathway are over-expressed, above normal levels, leading to
abnormal cellular growth. This concerted activity of multiple genes is often difficult
to observe at the individual interaction level.
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The functional modules extracted from data-driven networks allow biologists to
narrow down on the key biological processes that are active within a given set
of samples. Among the thousands of interactions within the data-driven network,
functional modules provide biologists with a smaller sub-set of interactions to focus
on. This dissertation develops an approach to identify functional modules within a
data-driven network, associated with both biological processes as well as phenotypic
conditions.
4.2 Relevant Work
In this section, I address approaches that have been developed to extract functional
modules from biological networks. In chapter 2, I discussed several approaches
for identifying sub-type specific modules from data as well extending the modules
to module networks. Here I discuss approaches for identifying modules within
protein-protein interaction networks.
Biological networks are often represented as graphs (both directed and undirected)
with the nodes representing genes (or proteins) and edges representing the presence
of an interaction between the two nodes. Consequently, graph theory is often applied
to solve problems in biological networks. For instance, Perreira et. al. [98] have
applied Markov clustering to extract functional modules from networks of yeast
protein-protein interactions. Markov clustering allows for graph clustering based on
flow between nodes in a network. Subsequently, Perreira et. al. extract the functional
significance of modules using the consistency of protein classifications within each
module. MCODE, proposed by Bader et. al. [99], extracts densely connected
regions corresponding to molecular complexes from protein-protein interaction
networks derived from yeast. Their algorithm uses a vertex weighting scheme which
estimates the extent to which a neighborhood forms a clique and uses this measure
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to extract complexes from protein-protein networks. Alternately, Palla et. al. [100]
extract overlapping community structures from protein-protein interaction networks.
Their approach relies on the definition of a community as consisting of several
complete (fully connected) sub-graphs sharing a large proportion of nodes. Using
this definition, communities in yeast protein-protein interaction networks have been
analyzed. Navlakha et. al. [101] use graph summarization to extract biologically
meaningful modules. The approach involves compressing the nodes in the original
network into supernodes (composed of a set of nodes) and has been applied to
the protein interaction networks derived from yeast. Speed and Performance in
Clustering (SPICi) [102] is another fast clustering technique which builds clusters
using a greedy approach. The algorithm starts from local seeds with a high weighted
degree to add nodes that maintain the density of the clusters and are adjacent to a
suitable fraction of nodes within them. SPICi has been applied to extract clusters
from yeast protein-protein interaction networks. However, the main shortcoming of
the existing methods is in incorporating phenotypic significance while extracting the
modules.
In this dissertation, I develop a method to identify functional modules within a
data-driven network. The methods developed here identify functional modules with
both biological significance and phenotypic significance. Hence, the methods are
focused on context-specific gene regulatory networks (GRNs) [46, 103] in order
to capture the phenotypic similarities encoded in the interactions. However, these
method could be easily applied to other data-driven networks including Bayesian
networks [104, 105] and ARACNE [32].
In addition to biological significance, drug target information is also associated with
the modules enhancing the therapeutic significance of the modules. The methods de-
veloped here are applied to two cancer gene expression datasets yielding insights on
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possible associations between tumor-types and several useful clinical implications.
Context-specific Gene Regulatory Networks
Prior to defining the problem of identifying functional modules, I describe context-
specific gene regulatory networks as they form the primary input to this work.
I begin by describing the building blocks of context-specific gene regulatory networks
– context motifs.
Context Motifs
In its simplest form, a context motif is represented as M = (G,T ) where G represents
a set of genes and T represents the set of samples under which the genes are expressed
consistently within the high throughput dataset. In order to identify context motifs,
the set of genes G is divided into driver genes (or drivers) and passenger genes (or
drivens), based upon the extent to which the genes exhibit consistent expression (i.e.,
genes with high coherency in expression are driver genes).
For a single gene, gi, assuming it is the driver gene for a given context-motif, two
probabilistic measures conditioning and crosstalk, are used, to identify passenger
genes that are coherently expressed along with gi. For simplicity, the expression
levels of all genes are assumed to be binary (ON or OFF), although the method
could be applied to more than two states. Two cases for gi are considered, namely
when the gene is ON and when the gene is OFF .
In the first case, when gi is ON, the statistic conditioning is used to measure for any
other (passenger) gene g j, the conditional probability of g j also being ON.
Definition 6 (Conditioning). Conditioning (δi j) is the extent to which contextual
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effects diminish the influence of a driver gene gi on a passenger gene g j.
P(g j = 1|gi = 1) = 1−δi j (4.1)
In the second case, when gi is OFF , the statistic crosstalk is used to measure the
probability that the state g j = 0 depends on contextual effects alone and not the
effects of drivers.
Definition 7 (Crosstalk). Crosstalk (ηi j) is the extent to which contextual effects
outside the driver gene gi activate a passenger gene g j.
P(g j = 1|gi = 0) = ηi j (4.2)
While the above definitions are provided for context motifs with a single driver genes
and binary expression levels, the definition of a context motif can be generalized to
a set of driver genes.
With this generalization, a context motif is represented as M = (D,Y,S,T ) where
D represents a set of driver genes, Y represents the state of the driver genes (e.g.,
Y ∈Qq whereQ = {0,1} and q = |Yi|, for a binary quantized dataset), S represents
a set of passenger genes and T represents the set of samples under which consistent
expression is observed. The hypergeometric test [45] corrected for false discoveries
using Benjamini and Hochberg’s method [106] is used in order to assess the statistical
significance of obtaining a context motif with a given crosstalk and conditioning. A
driver gene gi at activity level yi is said to regulate a passenger gene x j when the
conditioning δi j and crosstalk ηi j values are lesser than user-specified threshold δθ
and ηθ , with a statistical significance less than the user-specified threshold pθ .
53
Figure 4.1: Algorithm to learn context motifs from high-throughput data [45].
Context Motif Identification
Using the model described above, all potential context-motifs are identified from
data via a process called in-silico conditioning [45], a method designed to mimic a
biologist’s manipulation of the status of a gene in an experiment using techniques
such as ectopic expression or gene silencing. Given a gene gi, the expression of the
gene is first set to a certain state, yi, for example, ON. Then, the samples are divided
into two groups, based on the expression of the gene: the first group, Ti with all
the samples with gi = ON, and the second with all the samples with gi = OFF. The
crosstalk and the conditioning for the rest of the genes in the data are estimated to
determine which genes show consistent transcriptional activity. Note that a gene can
be set to multiple states (ON or OFF if binary), and each gene can be a driver for
multiple context motifs. In some cases, different genes can be conditioned across
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the same set of samples, leading to multiple driver genes in a context-motif. This
process is repeated for all the genes in the data to identify all potential context-motifs.
Figure 4.2 illustrates this process.
Additionally, the statistical significance of each context motif is estimated based
on its size (number of genes and samples). Given a context-motif M = (D,Y,S,T ),
the probability of obtaining a context-motif of l = |D∪S| genes or more by chance
is estimated using a permutation based approach. Specifically, the given data set
is randomly split into two groups of which one has a sample size of k = |T | and
the other has a sample size of N− k, where N is the total number of samples in
the dataset. The same set of statistics (Eqs. 4.1–4.2) are then used to identify the
number of genes filtered by the same thresholds for interference, crosstalk and
p-value. By repeating this procedure many times, Pr(L ≥ l |K = k) is estimated.
The accuracy of the estimation is based on the number of repetitions. 10,000
repetitions was used to build empirical distributions with adequate statistical power,
towards the applications described in this dissertation. The estimated probabilities for
context-motifs are subsequently corrected for false discoveries using Benjamini and
Hochberg’s procedure [106]. Using this re-sampling-based approach, the statistical
significance of identified context-motifs is found and only those with a significant
p-value are considered for further analysis.
Learning Contexts from Context Motifs
Following the identification of context motifs, the learned interactions can be chained
and cascaded to understand contextual genomic regulations. A given context motif
M = (D,Y,S,T ) defines regulatory relationships between the driver genes and the
passenger genes, i.e., gi→ g ∈ S, specific to T samples with gi (drivers) conditioned
on a specific state Y = yi. A driver g j in context C j could be driven by gi in
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another context Ci. When such relationships are added to the implicit driver-driven
relationships gi→ g j, an interesting graphical structure is obtained representing the
relationships between context motifs; this graph is called a context motif network. A
context motif network differs from other graphical representations in the fact that
context motifs connected to one another within the network differ in their sample
composition.
The context motif network represents a network of biological interactions where each
interaction is specific to a particular sub-set of samples. Typically, after filtering out
context-motifs that are statistically insignificant, this network tends to contain a few
hundred nodes and several thousand interactions. Further, while functional modules
can be seen in this network they are fairly difficult to discern visually, due to the size
of the network and the heterogeneity in the dataset, often resulting in interactions
conditioned by samples of different sub-types or clinical annotations. Therefore, it
is important to extract functional modules from the graph, by promoting regions
of strong connectivity – implying considerable overlap in sample composition and
removing edges with weaker connectivity between functional modules.
4.3 Problem Formulation
The task of identifying functional modules within data-driven networks poses several
challenges. Firstly, data-driven networks have a large number of nodes and con-
nections between the nodes, implying scalability is a desirable property. Secondly,
data-driven networks are obtained from high-throughput data which is heteroge-
neous being drawn from different samples with varying phenotypes. Consequently,
it would be relevant to identify modules which not only share a common function
but also have phenotypic similarities.
By definition, a functional module consists of set of densely connected nodes, with
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loose connections between the modules. It has input and output nodes controlling
interactions with the rest of the network. It also possesses internal nodes which do
not significantly interact with nodes outside the module [107]. Thus, regulation of
the biomolecules within a functional module is tight while the regulation between
functional modules tends to be fairly loose. Here the definition of a cut is particularly
useful.
Definition 8 (Cut). A cut is a partition of the gene network into two non-empty sets
S and V \S denoted by (S,V \S).
Usually a cut is uniquely defined by a set S, and hence any sub-set of V can be
called a cut. The cut-size is the number of edges that connects vertices in S to those
in V \S. Given this definition a clustering of the graph G into functional modules
M = (m1,m2, · · ·mk) possesses the property that the cut size between modules is
lower than the average connectivity within each module.
Definition 9 (Functional Module). A functional module mi is defined as a triplet
(Ci,Bi,Ti) where
• Ci is an induced subgraph of the graph, such that Ci = (Vc,Ec), where Vc ∈
V,Ec ∈ E; for every edge (u,v) ∈ Ec, u ∈Vc and v ∈Vc
• Bi is a set of biological processes (or pathways) significantly enriched in Ci,
and is non-empty.
• Ti is a set of clinical annotations significantly enriched in Ci, and is non-empty.
Based on the above definition, the functional modules identified within the computa-
tional gene network are mutually exclusive. However a single functional module
could be associated with multiple biological processes as well as a single biological
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process could be associated with multiple functional modules, as it is fairly common
to find individual genes participating in multiple biological processes (or pathways).
Given such a network, the task of discerning functional modules within the data-
driven network is viewed as a two-stage process. The first stage is to partition the
network into modules, where the nodes within each module are densely connected
and relatively isolated from the rest of the network. The second stage is to associate
known biological processes and clinical annotations to each module. The main
reason for doing this is in order to allow for flexibility in the biological knowledge
and clinical annotations associated with each module.
4.4 Discerning Modules
The first stage in identifying functional modules within the data-driven network is to
partition the network into modules.
Methodology
The goal of this stage is to identify modules within the data-driven network in such a
way that there are many edges within each module and relatively few edges between
modules. Although at a first glance this appears as a graph partitioning problem,
this is instead formulated as a clustering problem since balancing the sizes of the
clusters is not a key criterion in determining the modules. Further, as opposed to
conventional clustering, in this problem, similarity is expressed through whether
elements ‘share a property’ or not (such as a regulatory relationship where genes are
co-regulated), rather than the distance between the elements, steering towards graph
clustering approaches. The question ofcourse remains, as to whether to consider
supervision using a semi-supervised approach.
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Semi-supervised clustering aims to organize data points into clusters, using limited
amount of information in the form of pair-wise constraints between the data points.
Pairwise supervision is usually provided in the form of ‘must-link’ and ‘cannot-link’
constraints. A ‘must-link’ constraint indicates that the two data points in the pair
should be placed within the same cluster. A ‘cannot-link’ constraint indicates that
the two data points in the pair should belong to different clusters.
Semi-supervised clustering has successfully applied to several biological problems
[108, 109, 110, 111, 112, 113, 114]. Semi-supervised graph clustering [115] has
also been shown to be successful in clustering a gene interaction network from
yeast (with 216 genes). In the context of data-driven networks however, semi-
supervised clustering is not very desirable. Pairwise supervision could be introduced
in two dimensions - genes and samples. In the case of genes, pairwise supervision
would be by introducing ‘must-links’ between genes within the same biological
pathways or sharing biological functions. However, data-driven interactions learnt
from high-throughput data are association networks. Hence, a single computational
interaction often maps on to a path of biological interactions (as discussed in Chapter
3). This complicates the assignment of must-link constraints to the genes based on
known biological pathways. Directly using biological pathways to enforce must-link
constraints would not be applicable to data-driven networks.
Consequently, graph clustering approaches are used to discern modules from data-
driven networks . Specifically, two algorithms – Markov clustering and spectral
clustering were chosen for identifying functional modules within the data-driven
networks. Markov clustering was chosen due to its scalability and ability to auto-
matically determine the number of clusters. Spectral clustering was chosen due to
its ability to find an optimal minimum cut while creating well-balanced clusters. In
addition, previous successful applications of these algorithms in the bioinformatics
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field have yielded promising results [116, 117, 118, 119] indicating these algorithms
could be well-suited for this application.
Markov Clustering
The Markov clustering (MCL) algorithm derives its inspiration from the notion of
random walks in graphs. If a random walk visits a certain vertex in a cluster, it would
be likely to visit several other members of the cluster before leaving the cluster. [120]
The Markov clustering algorithm simulates flow using two (alternating) algebraic
operations on matrices. Expansion (identical to matrix multiplication) represents
the homogenization of flow across different regions of the graph. Inflation, mathe-
matically equivalent to a Hadamard power followed by diagonal scaling, represents
the contraction of flow, making it thicker in regions of higher current and thinner
in regions of lower current. Intuitively, expansion corresponds to augmenting the
neighbors of a given vertex, and inflation corresponds to promoting those neigh-
bors which have a higher transition probability from a given vertex. The Markov
clustering process causes flow to spread out within natural clusters and evaporate in
between different clusters [120]. The iteration is continued until a recurrent state or
fixpoint is reached.
The exact steps are explained in Algorithm 2. The connected components of the
graph induced by the non-zero entries of M provide the required clustering. Proof of
concept, mathematical properties and analyses on the complexity and scalability of
the algorithm can be found in [121].
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Algorithm 2 Markov Clustering
Input: G = (V,E), expansion parameter e, inflation parameter r
while M is not fixpoint do
M←Me
for all u ∈V do
for all v ∈V do
Muv←Mruv
for all v ∈V do
Muv← Muv∑w∈V Muw
end for
end for
end for
end while
Spectral Clustering
Spectral clustering uses the Eigen decomposition of matrix representations of a
graph to determine the optimal partitioning of the graph. Although, there has been
extensive research in the spectral clustering field, I use the algorithms developed by
Shi and Malik [122] – for symmetric clustering, and Meila and Pentney [123] – for
asymmetric clustering, because they incorporate information from the edges (in our
case, data-driven interactions) in determining the optimal clustering of a graph.
Symmetric Cuts: In graph theory, a cut is defined as
cut(A,B) = ∑
u∈A,v∈B
wuv, (4.3)
where A and B are the clusters resulting from the cut between vertices u and v.
Finding the minimum cut for Equation 4.3 could result in singletons or clusters with
very few nodes, leading to poorly distributed clusters. Thus, there exists a need
to balance the clusters. Shi and Malik, have proposed a solution to this problem
by normalizing the cuts that create clusters [122]. The cut cost is calculated as a
fraction of the weights of the edges in the induced sub-graphs. As finding the exact
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solution to the normalized minimum cut problem is considered NP-complete, the
authors have found that using the eigenvector corresponding to the second smallest
eigenvalue of the Laplacian of an undirected graph (also known as the Fiedler vector)
could efficiently provide an approximate discrete solution [122]. The algorithm,
referred to as the normalized cut algorithm, recursively splits clusters thresholding
the Fiedler vector of the induced sub-graphs until the desired number of clusters are
reached.
Asymmetric Cuts: Meila and Pentney [123] provide for the expansion of spectral
clustering in multi-way cuts to directed graphs, as the normalized cut is applicable
only to undirected graphs. In gene regulation directionality could provide useful
information. The weighted cut algorithm, proposed by Meila and Pentney, math-
ematically transforms a directed graph (with a non-normalized Laplacian matrix,
D-A), into a symmetric Hermitian matrix [123] and finds an approximate solution to
minimizing a normalized cut. Using the k eigenvectors pertaining to the k smallest
eigenvalues of the Hermitian matrix, the weighted cut algorithm applies the k-means
algorithm to cluster the graph. In addition, the algorithm allows for user input,
balancing parameters T and T ′ , to normalize the cuts produced by the algorithm.
Thus the normalized minimum cut for directed graphs can be expressed as:
MNCut(x) = min
zk∈Rnorthon
K
∑
k=1
z∗kH(B)zk (4.4)
where B = T−
1
2 (D−A)T− 12 , K is the number of desired clusters and H(B) is the
Hermitian matrix of B.
In this section I describe the comparisons between the algorithms and results obtained
from applying the previously described methods to two datasets - a refractory cancer
data set and a glioma data set.
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Comparing Graph Clustering Algorithms
In our first study, three spectral clustering variants are compared – symmetric spec-
tral clustering with two variants of asymmetric spectral clustering, using different
balancing parameters (the average cut and the out-degree cut).
Performance Metrics
I use the metrics coverage and performance [124] to compare the methods.
Definition 10 (Coverage). The coverage of a partitioning M is defined as the fraction
of intra-cluster edges (qm) within the complete set of edges (q), i.e
α(M) =
qm
q
=
qm
qm+qm
(4.5)
I choose this metric as it measures the wellness of a cut in a graph by taking the
edges within the cluster(s) of a graph as a fraction of all the edges. Thus, the smaller
a cut, the better the coverage it would have. Both a graph with no clusters at all and
a graph with several disconnected components would have a coverage of 1 due to
the absence of inter-cluster edges. Sparsity of the graph would not influence the
coverage as long as the intra-connectivity is much higher than the inter-connectivity.
Definition 11 (Performance). The performance of a partitioning M is the fraction
of intra-cluster edges together with non-adjacent pairs of nodes in different clusters
within the set of all pairs of nodes.
β (M) =
qm+∑v,w/∈E,v∈mi,w∈m j,i 6= j 1
1
2n(n−1)
(4.6)
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The performance of a partitioning M counts the number of ‘correctly interpreted
pairs of nodes’ in a graph. I choose this measure as a means to assess the connectivity
within the clusters of the graph. The fewer non-edges (pairs of nodes within the same
cluster but lacking an edge between them) there are within a graph, the higher its
performance would be. Further, a graph containing several singleton nodes, as well
as a fully connected graph with a single giant cluster, would both have a performance
of 1, as the number of non-edges would be zero in both cases. The goal is to
maximize connectivity within a cluster for better performance and by maximizing
intra-connectivity (approaching the number of possible edges of a graph), one can
minimize the inter-connectivity. It is notable however, that performance will not do
well in sparsely connected large graphs even when there may be substantially fewer
edges between clusters.
The above formulae are specific to undirected graphs. Direction when available is
associated with each edge e. In the case of directed graphs, the maximum number of
edges possible is twice as many as the edges possible in undirected graphs and the
formulae are correspondingly modified.
Comparing Symmetric against Asymmetric Spectral Clustering
In the first experiment, symmetric spectral clustering is compared against asymmetric
spectral clustering. The average of performance and coverage is used as a measure
of the wellness of the clusters, and is plotted against the number of clusters produced,
shown in Figure 4.2.
Spectral clustering performed well both on undirected graphs and directed graphs. I
notice that the asymmetric algorithms peaked at a higher number of clusters than
the symmetric algorithm. This implies that the normalized cut algorithm left intact
large, well connected clusters until a certain threshold was reached. I also note that
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Figure 4.2: Performance and coverage average of spectral clustering
Table 4.1: Performance comparison of Markov and spectral clustering.
Coverage Performance
Network 1 Spectral Symmetric 0.97 0.8
(391 nodes Spectral Asymmetric 0.95 0.6
6200 edges) MCL 0.94 0.77
Network 2 Spectral Symmetric 0.97 0.93
(1,901 nodes Spectral Asymmetric 0.71 0.88
33,820 edges) MCL 0.94 0.89
using the average cut exhibits less fluctuation in performance across different cluster
sizes than using the out-degree of the nodes, explained by the fact that the average
cut uses the number of nodes as the balancing parameter. However, if in fact a gene
regulatory networks follows a scale-free topology then the average cut may not prove
to be the most useful in identifying biologically significant clusters because it does
not take into account the interactions within a cluster.
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Comparing Spectral Clustering against Markov Clustering
In our second study, spectral clustering (symmetric and asymmetric) is compared
with Markov clustering. As seen in Table 4.1, in terms of coverage, spectral clus-
tering performed well over both directed and undirected graphs. In terms of perfor-
mance, the asymmetric case shows a lower performance value than the other two.
This indicates that incorporating directionality does not correspond with a significant
impact on the clustering, in terms of the performance metrics.
While both MCL and symmetric spectral clustering performed well on the much
larger dataset, exhibiting good scalability. However, the spectral clustering tech-
niques required the number of clusters to be pre-specified and this is often not
available in biological applications. Hence, for the biological study MCL was
applied.
4.5 Associating Biological Knowledge with Modules
Biological knowledge in the form of gene sets and the clinical categories of the
samples is used to associate functional significance to each extracted module.
Methodology
Here I describe the methods developed to identify enriched functional and clinical
annotations for each functional module.
Enriched Functional Annotations
To understand the biological relevance of the functional modules, I investigate the
functional enrichment of each module using pre-defined biologically relevant gene
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sets. The hypergeometric test is used to measure the significance of the enrichment
and the p-values are corrected for False Discovery Rate (FDR) using Benjamini and
Hochberg’s method [106]. The Molecular Signatures Database (MSigDB version
3.0) [49] and Pathway Commons (as of September 2010) [6] are used as reference
knowledge sources (described in Chapter 2).
Enriched Clinical Annotations
Context-specific gene regulatory networks [46] allow for associating samples with
each node (in this case context motifs) in the network. Based on the available clinical
annotations, I associate modules with enriched clinical associations.
Since every node has a set of samples associated with it, it is crucial to first associate
samples to the modular level based on the frequency of occurrence of samples across
the nodes within a module. The sample association score as described in [103] is
used for this association.
Definition 12 (Sample Association Score). Sample Association Score (L
(
s j ∈ mi
)
)
is the likelihood that a sample s j belongs to a module mi.
Let p be the total number of samples, si be the number of samples in a context motif
Mi; let mi be a module made of context motifs {M1,M2, . . . ,Mm} and the sample s j
is included only in a subset of mi,M ( j) ⊂ C . Then, the sample association score is
defined as:
L
(
s j ∈ C
)
=
∑s j∈Mi w(Mi)
∑i w(Mi)
.
where
w(Mi) = K
√√√√(1−(ki
N
)K)
, 1≤ K.
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Based on this definition I note that 0 ≤ L(s j ∈ C ) ≤ 1, where L(s j ∈ C ) = 0
indicates no appearance of the sample in any context motif, while L
(
s j ∈ C
)
= 1
indicates the presence of the sample in every context motif. The parameter K controls
the context-specificity of sample membership to a given module – the higher the K,
the more context specific the sample membership. For this application I set K = 2.
Only samples that had a sample association score > 0.9 were considered to be part
of a functional module.
Similarly, the probability that the sample s j belongs to the module C can be com-
puted as:
Pr
(
s j ∈ C
)
= 1− ∑
M j∈C
p
I(s j)
j
(
1− p j
)1−I(s j)
where p j = n j/N and I
(
s j
)
= 1 if s j ∈m j, 0 otherwise. In this study, the probability
Pr
(
s j ∈ C
)
was set to 0.05.
Only samples that had a sample association score > 0.8 were considered to be part
of a module. Following this, the modules were analyzed for enrichment of specific
clinical categories using the hypergeometric test. False discovery rate correction was
applied using Benjamini and Hochberg’s correction method [106].
Survival Analysis
When survival information was available for the dataset, Kaplan-Meier survival
analysis [125] was performed on the samples belonging to each of the functional
module with respect to all other samples within the dataset. The chi-squared test
was used to identify significant differences in survival.
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Drug Annotations
Additionally, drug associations were also studied using drug target information from
Drugbank [62]. Drug targets were extracted from the Integrated Druggable list (from
Sophic Alliance 1) consisting of an integrated list of genes determined druggable.
The list contains information from four sources, of which two sources were used -
the list published by Hopkins & Groom [126] and by Wishart [62] as they were the
most reliable.
In summary, Figure 4.3 illustrates the procedure for identification of functional
modules from a data-driven network and the nature of the inputs and outputs at each
stage.
Application: Refractory Cancer (Target Now)
I now demonstrate the biological application of the methods developed in this
dissertation. I use the Target Now (TN) [127] cancer data set. The Target Now study
was conducted on refractory cancer patients who did not benefit from standard types
of treatment. Late stage cancer is frequently de-differentiated, having lost a great
deal of the specialized functions present in the tissue from which it arose. The TN
study aims to determine if the patients could derive benefit from therapy with a drug
not normally used for their particular form of cancer [127].
The Target Now gene expression profiling experiments were conducted using the
Agilent 011521 Human 1A Microarray G4110A platform. Table 4.2 shows the
number of samples corresponding to each tumor type. The study consists of 146
patients, spanning 35 different types of tumor. The dataset was filtered based on the
1http://www.sophicalliance.com/
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Figure 4.3: Flowchart for the identification of functional modules from a data-driven
network. The region enclosed within a dashed rectangle indicates the contributions
of this work.
transcription activity of each gene across samples, and reduced to 3,851 genes by
eliminating genes with a low variance across samples.
Table 4.2: Distribution of samples in the Target Now data set.
Pancreas 20 Colon 7 Brain 4 Cervical 3 Esophagus 2
Ovarian 19 Kidney 6 Lung 4 Gallbladder 3 Skin 2
Melanoma 18 Salivary 6 Adipose 3 Rectal 3 T Cell 2
Breast 16 Adrenal 5 Bladder 3 Stomach 3 Thyroid 2
Single Sample: Appendix, Cartilage, Chondrosarcoma, Prostate, Testicular,
Glioma, Gastric, Ileum, Lymphoma, Monocytes, Eccrine Adenocarcinoma,
Rhabdomyosarcoma, Synovial Cell Sarcoma, Skeletal Muscle, Uterus
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The context mining algorithm was applied using a crosstalk < 0.3, conditioning
< 0.1 and statistical significance < 0.05. Further, for each context motif (with x
genes) the probability of obtaining a context-motif of x genes or more by chance,
was computed, and context-motifs with a statistical significance greater than 0.01
were filtered out. Subsequently Markov clustering was applied using an inflation of
1.4 and a total of 28 functional modules were obtained.
Figure 4.4: Functional modules in refractory cancer (TN).
Enriched tumor types and functional annotations were identified corresponding to
these functional modules. Single sample tumors were omitted from the phenotypic
enrichment analyses and a statistical significance threshold of 0.05 was used for all
functional enrichment. Of these, functional modules with fewer than 10 genes and
fewer than 10 samples were eliminated, and the resulting functional modules are
shown in Table 4.3. As seen in the table, several interesting tumor type associations
were identified.
71
Starting with module 1, enriched with kidney and breast tumors, it is heartening to
see the Wnt/Ca2 signaling pathway enriched in this functional module, confirming
the importance of the role of this pathway in multiple tumor types. Amongst the
genes, DHFR was identified as a potential drug target, currently being targeted by the
drug methotrexate [128, 129] in multiple tumors including renal and breast tumor.
Within this functional module, I also identified four other genes to be druggable
(shown in Table 4.3). Of particular interest is the gene, PDE4C, which is targeted
by the drugs Ketotifen and Iloprost. The randomized phase II trial (NCT00084409)
studied how well Iloprost works in preventing lung cancer in patients who are at
high risk for this disease.
Module 5, enriched with pancreatic tumor contains, in addition to RRM2, the drug-
gable gene TYMS, a well-known target for several drugs (Raltitrexed, Gemcitabine,
Fluorouracil, Pemetrexed, Capecitabine) currently being used to treat the disease.
This module also contains the druggable gene PSMB1 (targeted by Bortezomib).
Within module 7, apart from the genes C1QA, C1QB and FCGR3A, currently being
targeted by several anti-neoplastic drugs, it is interesting to note the presence of the
gene ITGB2 currently being targeted by Simvastatin [130].
Finally, in module 10, of interest are the genes C1R, C1S and PDGFRA all being
currently targeted by several anti-neoplastic drugs. Additionally, it is interesting to
note the gene PROS1, targeted by the drugs, Drotrecogin alfa (currently being inves-
tigated for treating sepsis associated with cancer [131]) and Menadione (currently
being used to treat the disease [132]).
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Application: Glioblastoma Multiforme (TCGA)
Next, I study the ability of the methods developed in this chapter to identify func-
tional modules within brain tumor. The TCGA GBM data set (described in chapter
3) was used for this purpose. The context mining algorithm was applied using a
crosstalk < 0.3, conditioning < 0.1 and statistical significance < 0.01. Further, for
each context motif (with x genes) the probability of obtaining a context-motif of
x genes or more by chance, was computed, and context-motifs with a statistical
significance greater than 0.01 were filtered out. Markov clustering was applied using
an inflation of 1.4 and extracted a total of 31 functional modules were obtained.
Enriched tumor types and functional annotations were identified corresponding
to these functional modules with a statistical significance threshold of 0.05. Of
these, functional modules with fewer than 10 genes and fewer than 10 samples were
eliminated, and the resulting functional modules are shown in Table 4.5.
Table 4.5 shows the context-specific gene regulations extracted from this data
along with enriched clinical associations, enriched functional annotations. Drug
associations for each functional module are shown in Table 4.5, showing specifically
the anti-neoplastic drugs currently used to target the genes. It is interesting to note
that C1 and C2 are enriched with NF1 and PTEN mutations respectively, previously
reported to be characteristic of the Mesenchymal subtype [133]. Additionally, C7
enriched with the Proneural subtype is also enriched with the TP53 mutation.
Further, survival analysis was performed on each of the functional modules against
the samples in the rest of the data and three functional modules were identified to
show significant survival differences (shown in Figures 4.6, 4.7 and, 4.8). Functional
module C7, enriched with the proneural subtype, shows significantly longer survival
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Figure 4.5: Functional modules in glioblastoma multiforme (TCGA).
than the rest of the patients, while the functional modules C2 and C4, enriched with
the mesenchymal subtype show significantly shorter survival differences than the
rest of the patients.
4.6 Summary
In summary, a method for the identification of functional modules in data-driven
networks has been proposed. In comparison with other clustering algorithms, Markov
clustering was found to be the most promising in identifying functional modules.
Interestingly, the direction of the interactions did not play a role in the clustering.
Functional modules were extracted from both a refractory cancer dataset and the
TCGA glioma dataset. Interesting tumor type associations and therapeutic targets
were identified for each functional module within each dataset.
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Figure 4.6: Kaplan Meier curve showing survival of C2 against the rest.
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Figure 4.7: Kaplan Meier curve showing survival of C4 against the rest.
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Figure 4.8: Kaplan Meier curve showing survival of C7 against the rest.
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Table 4.5: Drug targets for the functional modules (TCGA).
Module Drug Drugs
Targets
C1 CD33 [Up] Gemtuzumab ozogamicin;
SYK [Up] Sti-571;
ALOX5 [Up] Leflunomide;
C2 FCGR2A [Up] Cetuximab; Gemtuzumab ozogamicin; Trastuzumab;
Rituximab; Ibritumomab; Tositumomab; Alem-
tuzumab; Bevacizumab;
C6 C1QC [Up] Cetuximab; Gemtuzumab ozogamicin; Trastuzumab;
Rituximab; Ibritumomab; Tositumomab; Alem-
tuzumab; Bevacizumab;
FCGR3A [Up] Cetuximab; Gemtuzumab ozogamicin; Trastuzumab;
Rituximab; Ibritumomab; Tositumomab; Alem-
tuzumab; Bevacizumab;
C1QA [Up] Cetuximab; Gemtuzumab ozogamicin; Trastuzumab;
Rituximab; Ibritumomab; Tositumomab; Alem-
tuzumab; Bevacizumab;
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Chapter 5
LEARNING RELATIONSHIPS BETWEEN BIOLOGICAL PROCESSES
While the previous chapter dealt with identifying functional modules within a high-
throughput data set, often we are interested in a higher level of abstraction – de-
termining relationships between the biological processes that are active within a
group of patients. In this chapter, I discuss the motivation for studying relationships
between biological processes, relevant work in this area, the methodology developed
in this dissertation and the relationships between biological processes, identified
within a glioma data set.
5.1 Motivation
Biological processes, analogous to functional modules (described in the previous
chapter) represent groups of genes or proteins with a common purpose. Understand-
ing relationships between biological processes, specifically, the co-occurence of
biological processes allows biologists to focus on the broad-level pathways that are
active within a given phenotype. Additionally, it also permits discovery of potentially
novel relationships between biological processes.
This chapter develops a method to identify the biological processes that are active
within high-throughput data and understand the variations in activity across different
sub-sets of patients. While the previous chapter resulted in functional modules
for biologists to focus on, here, I develop a mechanism which allows biologists to
identify a set of co-occurring biological processes that they are interested in. Further,
the method developed here uses not only data-driven information on the activity
of a biological process but also existing semantic relationships between biological
processes.
84
5.2 Relevant Work
In this section, I outline methods which use relationships between biological pro-
cesses or pathways. A few approaches have been developed for scoring pathways
over-represented in data. Such methods are similar to annotation approaches and
additionally incorporate pair-wise relationships between the genes within the path-
ways in scoring the pathways. For example, Rahnenfuhrer et. al. [134] propose a
method to rank pathways within an expression dataset using several similarity mea-
sures (correlation, covariance, dot product and cosine similarity) applied between
pathways. Gene expression data has also been used to rank pathways significantly
represented within the data [135, 136]. However, such methods identify pathways
by observing the activity of a pathway across all samples. Biological processes are
heterogeneous, implying that the same pathway could be activated in completely
different ways in different samples. Hence, it is essential to understand pathway
activity on a per-sample basis.
Pathway activity in gene expression has been studied on a per-sample basis using
signal transduction pathways [137], however the approach allows viewing the ex-
pression of individual pathways one at a time, rather than learning relationships
between pathways.
Chagoyen et. al. [138] quantify the functional coherence of Gene Ontology bio-
logical process terms using the Gene Ontology annotations of a literature-derived
protein-protein interaction network for yeast. Statistically significant functional
connections are then extracted. While this approach provides a mechanism to extract
novel functional relationships as well as analyze a literature-driven network, this
approach cannot be applied to identify relationships from high-throughput data.
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A few methods have been developed in order to study the co-occurrence of func-
tional terms. Del pozo et. al. [139] propose a method to derive functional distances
between Gene Ontology terms using the simultaneous occurrence of terms within
gene annotations using the cosine similarity metric. Similarly the QuickGO browser
1 allows for viewing similar terms based on other terms that a protein is annotated
with. However, the key limitations of such approaches is the lack of integration of
biomedical data in learning relationships between the biological processes. Conse-
quently, such methods only allow for learning the relationships between existing
biological processes. Learning novel associations between biological processes (or
pathways) is difficult to achieve.
This chapter focuses on developing a method to identify co-occurrence relation-
ships between biological processes using both existing relationships as well as the
over-representation of the biological processes within high-throughput data. Several
contributions are made in this chapter. Firstly, relationships between biological
processes are captured by exploiting the biological processes active in each sam-
ple individually, accounting for heterogeneity within the data. Secondly, existing
knowledge of relationships between biological processes is used to guide the process.
5.3 Problem Formulation
In this section, I mathematically formulate the problem of learning relationships
between biological processes. Given an n× p high throughput dataset D = (B,S)
where
• B = (b1,b2...bn) is the set of n genes (cellular/biological entities).
• S = (s1,s2...sp) is the set of p heterogeneous samples (or patients).
1htt p : //www.ebi.ac.uk/QuickGO
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• D(gi,s j) ∈ R represents the activity of gi in sample s j .
I assume biological knowledge is in the form of a set of terms P = {t1, t2, · · · , tk}
where each term t is an element in G, a directed graph. In this chapter, Gene
Ontology (GO) is considered as a biological knowledge source.
Using this, I am interested in identifying one or more sets of co-occurring bio-
logical processes Ps =
{
t(s)1 , t
(s)
2 , · · · , t(s)k
}
within D. Similar to functional modules
(described in chapter 4), such sets could be associated with clinical annotations.
However, unlike functional modules, these co-occurring biological processes are not
identified within a data-driven network but instead directly from the high-throughput
data.
5.4 Identifying Patient-specific Biological Processes
I now turn to the methodology used to identify co-occurring biological processes.
However, first it is essential to identify the biological processes active in a single
sample.
Given a set of x co-regulated genes for a specific sample (both up- and down-
regulated), out of a total set of X genes, I am interested in the ratio of co-regulated
genes that are annotated by the GO term(y) to the total number of genes annotated
by the GO term(Y ). The ratio y/Y is a measure of the extent to which the genes
annotated by a GO term are present within the co-regulated genes and is termed the
enrichment ratio.
The statistical significance of this ratio is assessed using the hypergeometric test.
This test is used as I sample from the data without replacement. The probability of
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randomly obtaining y or more genes enriched within a gene list is computed as
p =
x
∑
i=y
(X−y
x−i
)(y
i
)(X
x
) (5.1)
For a given sample, a set of terms P1 is found by extracting the statistically sig-
nificant terms (p-value lesser than 0.05). The set Pa comprises a set of GO terms{
t(a)1 , t
(a)
2 , · · · , t(a)q
}
and enrichment ratios
{
e(a)1 ,e
(a)
2 , · · · ,e(a)q
}
for the GO terms.
A naive approach would be to build a matrix of the activity of the GO terms across
the samples and then cluster this matrix. However, this approach fails to take
into account the existing relationships between GO terms. Hence, I move towards
developing a similarity metric between samples based on the GO terms activated in
each sample.
5.5 Quantifying the Similarity between Patients
Let P1 =
{
t(1)1 , t
(1)
2 , · · · , t(1)q
}
and P2 =
{
t(2)1 , t
(2)
2 , · · · , t(2)m
}
denote sets of GO terms
where each term t is an element in G, a directed graph.
The similarity of the two sets P1 and P2 is defined as
η(P1,P2) = κ ∗SK(P1,P2)+(1−κ)∗SD(P1,P2) (5.2)
where SK(P1,P2) is the knowledge-driven similarity between P1 and P2 obtained
from the Gene Ontology, SD(P1,P2) is the data-driven similarity between P1 and
P2 obtained from the enrichments of the terms contained in P1 and P2 within the
high-throughput data and κ is a parameter that controls the relative influence of data
and knowledge.
88
Data-driven Similarity
The data-driven similarity between the two samples can be computed using the
correlation of the expression of the genes in the dataset across the two samples.
Ideally, the high-throughput data set could be filtered to focus on the most variable
genes.
Knowledge-driven Similarity
The knowledge-driven similarity between the two terms could be computed in
multiple ways – either by using the enrichment ratios of the GO terms that the two
samples are annotated with, or through the semantic similarity between the GO
terms that the two samples are annotated with.
Enrichment Similarity
One way of expressing the knowledge-driven similarity is to capture the over-
representation of the terms within the high-throughput data. For a pair of samples,
two sets of terms P1 and P2 are found by extracting the statistically significant
terms (p-value lesser than 0.05) using the method previously described. Each set
Pa is associated with a set of GO terms
{
t(a)1 , t
(a)
2 , · · · , t(a)q
}
and enrichment ratios{
e(a)1 ,e
(a)
2 , · · · ,e(a)q
}
for the GO terms.
Definition 13 (Enrichment Similarity). The enrichment similarity, E(P1,P2) rep-
resents the extent to which the two sets of terms are both over-represented within a
high-throughput data set.
The enrichment similarity is found by
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E(P1,P2) = 1− [
m
∏
i=1
(1−
√
e(i)1 ∗ e(i)1 )] (5.3)
where m = |P1∪P2|. The enrichment similarity is formulated similar to the knowl-
edge overlap used in chapter 4.
Semantic Similarity
On the contrary, the knowledge-driven similarity could also be expressed through the
semantic similarity. The semantic similarity between two sets of terms represents the
extent to which the two sets of terms are referring to the same biological concepts.
Several methods have been developed for studying the semantic similarity between
terms and extended to sets of terms. Such methods are broadly categorized into
graph-based similarity measures and information-content based methods. Graph-
based methods use the directed acyclic graph encoding of an ontology in order
to compare terms. The semantic value of a given term is computed based on the
aggregate contribution of all the terms within the DAG, such that terms that are
closer to a term t contribute more to its semantics [140]. Alternately, information-
theoretic methods of semantic similarity have been addressed in several studies
[141, 142]. The idea behind such methods is to utilize the usage of terms within
the corpus. Comparisons of the two classes of methods [143, 144] have shown that
information-theoretic methods, specifically Resnik’s method correlates with gene
sequence similarities and gene expression profile better. Hence, in this work, the
semantic similarity is derived from information theory principles.
Prior to computing the semantic similarity between two sets of terms, it is first
necessary to quantify the information contained within a single term t.
Definition 14 (Information Content). The information content (i(t))) for a Gene
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Ontology term quantifies the semantic content within the term.
For a term t in G, this is defined as
i(t) = 1− log|At |
log|∪nk=1 Ak|
(5.4)
where At is the set of genes annotated with the term t and n is the total number of
terms in G. The idea behind this equation is that a term which annotates a high
proportion of genes would be a fairly common term and hence its semantic content
would be low [142]. On the contrary, a term which annotates few genes would be
one which is much less common and hence more meaningful.
Table 5.1: List of the annotation weights for the GO evidence codes.
Category Weight
Experimental :
EXP, IDA, IPI, IMP, IGI, IEP, TAS 1
Computational:
ISS, ISO, ISA, ISM, IGC, IBA, IBD, IKR, IRD, RCA 0.75
Author Statement / Automatically Assigned :
NAS, IC, ND, IEA 0.50
Gene annotations are usually curated using different methods, each with varying
reliabilities. GO uses evidence codes to assign reliabilities to each annotation and I
incorporate this in the information content. First numeric weights are assigned for
each evidence code as shown in Table 5.1. Subsequently, given At = (b1,b2, · · ·bp)
a set of p genes annotated with the term t and the reliability of each annotation
(r1,r2, · · ·rp), the size of the set At could then be modified to be computed as the
sum of the reliabilities of the terms within the set.
|At |=
p
∑
i=1
ri (5.5)
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After this, the semantic similarity between two terms is defined by tracing the path
of each term to the root of G [141].
Definition 15 (Semantic Similarity). The semantic similarity, d(t1, t2) for the Gene
Ontology terms t1 and t2 is the extent to which the two terms refer to the same
biological concept.
d(t1, t2) =
2∗maxt∈γ(t1,t2) i(t)
i(t1)+ i(t2)
(5.6)
where γ is the set of common subsumers to both terms t1 and t2. In the case of
GO, I focus on the tree corresponding to biological processes. Amongst the path
common to the two nodes, the information content of most specific term is used as
the common information content between the two nodes. Additionally, in order to
incorporate the depth of the two nodes, the information content of the two nodes
themselves are also used. The intuition behind this measure is to capture what is
common between the two terms. The common ancestor represents the information
content that is shared by the nodes.
Finally, the semantic similarity between the two sets S(P1,P2) is computed by taking
the average of the top h proportion of all pair-wise semantic similarity values. A
reasonable starting point for h would be 10 %. The intuition behind this is to capture
the most specific terms, and these are represented by the terms with a high semantic
similarity.
The similarity metric developed here (η) could then be applied to cluster data by
taking into account not only the similarity in expression and but also relationships
between the biological processes.
I now turn towards the results obtained while applying these methods to a high-
throughput cancer data. GO annotation and ontology files as of February 2012
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were used in this work. The ontology was filtered to remove all leaf nodes with no
annotated genes or proteins.
Clustering Glioblastoma Multiforme (GBM) Patients
The methods developed here were applied to the glioblastoma multiforme data set
described in [145]. This dataset consists of 181 WHO grade IV astrocytoma and
14 non-neoplastic samples from autopsy specimens of cerebral cortex from donors
with no history of brain tumor or neurological disorders obtained from the National
Neurological Research Brain Bank (Los Angeles, CA). The data was centered using
the median of all samples and quantized using a fold change of 1. Co-regulated genes
(both up- and down-regulated) were then extracted for each sample. Following this,
enriched biological processes were found for each sample using the hypergeometric
test and enriched terms were identified using a corrected p-value threshold of 0.05.
Of the 195 samples, only 160 samples had any term enrichments and these were
used in all subsequent analyses.
Clustering Samples
The first experiment involved clustering the samples using the three variants of the
similarity metric, described previously – pure data-driven similarity and knowledge-
driven similarity through the enrichment similarity as well as the semantic similarity.
Consensus k-means clustering [146] was applied for 100 iterations, varying the
number of clusters from 3 to 8. Table 5.2 shows the proportion of samples with
a positive silhouette score. As seen in the table, the best performance is achieved
when the semantic similarity is used to cluster the samples, at k = 3. Additionally, it
is also interesting to see that a purely data-driven metric performs much worse than
a knowledge-driven metric.
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Table 5.2: Proportion of samples with a positive silhouette score across varying
number of clusters (k).
Proportion of Samples With Positive Sil-
houette Score
k = 3 k = 4 k = 5 k = 6 k = 7 k = 8
Co-expression 69% 72% 72% 69% 70% 75%
Enrichment Similarity 81% 77% 71% 67% 41% 61%
Semantic Similarity 93% 74% 69% 66% 67% 69%
Focusing on the semantic similarity as a metric for clustering, Figure 5.5 shows the
consensus heatmaps for number of clusters varying from 3 – 6. The heat map shows
the proportion of times that the two samples occupy the same cluster. From the
heatmaps, it is clear that setting k at 3 results in clear clusters. It is also interesting
to note the presence of additional sub-groups although not very clear, indicating that
the data does contain additional sub-groups, however, these sub-groups could be due
to a smaller sub set of the biological processes.
Silhouette width values were computed for each sample [147] and only samples
with a positive silhouette width were used in further analysis. Silhouette scores
reflect whether the assignment of a sample to a cluster is appropriate. Positive scores
indicate that a sample is more similar to its own cluster than neighboring clusters.
Negative scores indicate samples are assigned to the wrong cluster [147]. Figure
5.5 shows the silhouette plots obtained for k = 3–6. As seen in the figure and in
Table 5.2, setting k at 3, resulted in the fewest number of poorly clustered samples.
Hence, for all further analyses, k was set to 3 and samples with a negative silhouette
score were omitted, leaving a total of 149 samples.
Biological Significance
The obtained clusters were analyzed for enriched clinical subtypes using the chi-
squared test, after applying a p-value filter of 0.05. Additionally, survival analyses
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Figure 5.1: Consensus heat maps showing patient clusters in glioblastoma multi-
forme (GBM). Yellow indicates that the two samples have a high consensus index
while red indicates a low consensus index.
was performed on the clusters and the co-occurring biological processes were iden-
tified in each cluster by extracting the GO terms which occurred most frequently
across the samples within a cluster. Specifically, I extracted terms which occurred
in atleast 50 % of the samples within a cluster. Table 5.3 shows a summary of the
clusters. Figure 5.5 shows the Kaplan-Meier survival plots for the three clusters.
It is interesting to see that the biological significance of the clusters matches pre-
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Figure 5.2: Silhouette plots for k = 3-6 showing the ’true’ samples of each cluster.
viously reported findings. Survival curves were generated using the Kaplan-Meier
analysis and are shown in figure 5.5. Cluster 1 enriched with the proneural subtype
was found to have better prognosis, while cluster 3, enriched with the proliferative
sub-type was found to exhibit poor prognosis. Contrary to previous findings how-
ever, cluster 2, although enriched with the mesenchymal sub-type, had a median
survival of 1.17 years, due to the presence of a few long surviving proneural and
mesenchymal samples within the cluster.
Additionally, clusters 1 and 3 showed significant survival differences with a p-value
of 0.036, and clusters 2 and 3 also showed significant survival differences with a
p-value of 0.008. The findings also confirm the associations between prognosis and
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Figure 5.3: Kaplan-Meier survival curves for clusters of biological processes identi-
fied in GBM.
the different stages in neurogenesis. The better prognosis subgroup (Cluster 1) is
enriched with neurogenesis biomarkers while the poor prognosis group (Cluster
3) was enriched with cell cycle biological processes indicating tumor proliferation.
An interesting find is that the normal samples cluster with the proneural sub-type.
Further the presence of signaling biological processes within cluster 1, associated
with the proneural subtype in addition to the previously reported angiogenesis, could
provide insights onto novel characteristics of the proneural sub-type.
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Effects of Relative Proportion of Knowledge and Data on Clustering
Finally, an experiment was performed to study how varying the amount of knowledge
(against data) would affect the clusters. Equation 5.2 was applied by varying κ
between 0 and 1. When κ = 0, this represented the case when only the correlation
of expression values was used for clustering. When κ = 1, this represented the case
when only the semantic similarity was used for clustering. Again, the proportion
of samples with a positive silhouette score was used to evaluate the clusterings and
the results are shown in Table 5.4. Interestingly, as the proportion of knowledge is
increased, the clusterings with k = 3 and 4 (previously reported by [145, 133]) are
identified with greater accuracy.
Table 5.4: Proportion of samples with positive silhouette score across varying
amounts of knowledge.
Proportion of Knowledge k=3 k=4 k=5 k=6 k=7 k=8
0% 68% 72% 69% 68% 71% 70%
10% 71% 75% 68% 68% 66% 69%
20% 68% 79% 68% 68% 64% 60%
30% 71% 71% 68% 69% 71% 78%
40% 81% 83% 78% 77% 73% 72%
50% 94% 84% 78% 79% 77% 59%
60% 82% 88% 49% 77% 71% 75%
70% 83% 91% 76% 77% 69% 78%
80% 93% 94% 81% 73% 69% 61%
90% 94% 94% 83% 79% 64% 65%
100% 95% 74% 66% 72% 57% 59%
5.6 Summary
This chapter has dealt with a method to identify co-occurrence relationships between
biological processes using both known relationships between biological processes
and their over-representation within a data set. The methods developed here have
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been applied to a high-throughput glioma data set. Co-occurring biological processes
were extracted in the form of three clusters, enriched with previously identified bio-
logical sub-types. Further statistically significant survival differences were obtained.
Additionally, potentially novel relationships between biological processes were also
identified.
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Chapter 6
CONCLUSION
Identifying plausible data-driven hypotheses using existing knowledge is an impor-
tant problem in computational systems biology. In this dissertation, I have developed
methods for addressing this problem based on hypotheses which fall into three
classes – individual interactions, functional modules and relationships between bio-
logical processes. Here I summarize the key contributions of this dissertation and
directions for future research.
6.1 Contributions
Individual Interactions
In Chapter 3, I have developed a method to evaluate data-driven interactions against
literature-derived pathways. Using the data-driven networks from three sources
(ARACNE, Bayesian networks and context-specific networks), I have shown how
≈ 60-70% of the interactions within these networks map onto literature-derived
paths (refer Table 3.1). Further I have shown how the evaluation of the data-driven
networks could shed light on several interesting properties of biological networks.
For a given network size, the proportion of data-driven interactions evaluated against
literature-derived pathways is similar across networks learnt using different methods.
It is also interesting to note that random networks created using the same set of nodes
as the data-driven network results in comparable statistics (shown in Figure 3.1 and
3.2). Additionally, I have also learnt that the integration of multiple knowledge
sources plays an important role in such validation efforts, with more than 75 %
data-driven edges, in all three data-driven networks, requiring a combination of two
or more sources for their validation.
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Since a significant proportion of the data-driven interactions do not correspond
to literature-derived paths, I have developed a scoring method to use additional
knowledge sources in determining the likelihood that each of these interactions are
plausible novel biological interactions. The scoring method for unmapped interac-
tions allows for the extraction of the best candidate hypotheses from the data-driven
interactions which could be validated with wet-lab experiments. Using a simulated
data set, I have shown that the scoring metric is able to distinguish between true and
false data-driven interactions (difference in distributions is statistically significant
with a p-value of 4.61× e−24). This metric copes with both incompleteness in
biological annotations as well as missing connections in literature-derived pathways.
Finally, these methods are applied to score the data-driven interactions in a glioma
dataset and identify plausible novel hypotheses.
Functional Modules
Moving to a higher level of abstraction, in Chapter 4, I develop a method to identify
functional modules from data-driven networks using graph clustering approaches.
Amongst the graph clustering algorithms, I observe that Markov clustering has
a tendency to extract biologically significant functional modules, even when the
directionality of the data-driven interactions is ignored.
I show how the methods could be applied to a refractory cancer data set, resulting
in several interesting tumor-type associations (shown in Figure 4.3 and Table 4.3)
between Kidney and Breast tumor; Bladder, Cervical and Rectal; and Brain and
Melanoma. Several interesting drug associations were found for the functional
modules and many of the identified drug targets were shown to be associated with a
drug currently treating some type of cancer, indicating that it could be used towards
the tumor in question.
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The methods were also applied to a the TCGA glioma data set. Functional modules
were found to be enriched with previously discovered sub-types (shown in Table
4.4). Additionally, the modules enriched with the Mesenchymal sub-types were
characterized by poor prognosis while the module enriched with the Proneural sub-
type was characterized by better prognosis (survival curves are shown in Figures 4.6
– 4.8).
Relationships between Biological Processes
At the level of the relationships between biological processes, I have developed a
method to identify co-occurrence relationships among biological processes within
a high-throughput data set, capturing the variations in pathway activity across the
samples within a given data set. Subsequently, I have developed an approach to
evaluate the similarity between samples using both data-derived metrics as well as
knowledge-derived metrics.
Interestingly, using knowledge-derived metrics for similarity proved to be more
effective than data-derived metrics in clustering biological processes. The approach
has been applied to the TCGA glioma data set to identify three sub-groups within
the data, confirming previous findings (shown in Table 5.3). The sub-groups cor-
responded to the different stages in neurogenesis, with the sub-group for better
prognosis (Cluster 1) enriched with neurogenesis biomarkers, while the sub-group
for poor prognosis (Cluster 3) was enriched with cell cycle biological processes
(shown in Figure 5.3).
The relative influences of knowledge and data on the clustering results was also stud-
ied (seen in Table 5.4), showing that overall, an increase in knowledge corresponded
with better clusters, in the cases of k = 3 and 4 (previously identified sub-groups).
This demonstrates that prior knowledge is an important aspect which could be used
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to guide the identification of co-occurring biological processes.
6.2 Future Work
While this dissertation has developed methods for identifying plausible biological
hypotheses from data-driven hypotheses, there remain several directions for further
research.
This dissertation develops methods to refine hypotheses. Currently the approaches
are implemented as a suite of tools. An interesting question is the large-scale appli-
cation of these approaches to identify novel hypotheses from high-throughput data.
Specifically, can we create a repository of data-driven hypotheses for community to
both utilize and augment?
Secondly, the method developed in this dissertation have been developed as a set of
independent tools that could be applied to data-driven hypotheses. As a next step,
it would be interesting to study the relationships between these tools. Specifically,
could the functional modules identified in chapter 4 be used as input to methods
for scoring interactions in chapter 3 ? If so, could we compare the evaluation of
data-driven interactions across different functional modules ?
Finally, this dissertation has used existing knowledge sources such as Gene Ontology
and pathways. An interesting aspect would be extension of this dissertation to use
additional sources such as transcription factors, microRNA information to understand
the extent to which these knowledge sources could allow for identifying plausible
biological hypotheses.
In summary, this dissertation opens up several possibilities for the effective utilization
of data-driven hypotheses using existing biological knowledge, making a significant
contribution to the field of knowledge discovery in systems biology.
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